祖龍娛樂發佈2024年中期業績

財務摘要︰- 2024年上半年收益為人民幣439.4百萬元,較2023年同期增長9.2%。其中,綜合遊戲發行及運營業務收益同比增長25.0%至人民幣 376.5百萬元,佔總收益的85.7%。- 2024年上半年毛利為人民幣321.7百萬元,較2023年同期增長8.1%,毛利率為73.2%,与去年同期基本持平。- 2024年上半年研發開支同比減少11.7%至人民幣264.1百萬元,銷售及營銷開支同比小幅上漲5.0%至人民幣172.7百萬元。- 2024年上半年經調整虧損淨額較2023年上半年同比收窄44.0%至人民幣120.4百萬元。營運摘要︰- 截至2024年中期業績公告發佈之日,集團在逾170個地區市場推出21款精品手遊,覆蓋MMORPG、SLG、女性向等多種遊戲類型,支持14種語言的多個地區版本。 - 女性向手遊《以閃亮之名》自2023年3月24日首次上線中國大陸地區以來,十餘次衝入iOS遊戲暢銷榜前十名。該遊戲依託成熟高效的研發及運營管理定期上線更新活動,展現了持續穩定的長線表現。截至2024年6月30日,《以閃亮之名》的全球累計用戶數超過1,600萬。 - SLG手游《三國群英傳:鴻鵠霸業》於2024年7月13日在中國大陸地區正式上線,並計劃於第四季度在中國港澳台地區上線。 - 經典遊戲《龍族幻想》、《鴻圖之下》等仍在持續進行運營投入,遊戲表現穩定並為集團持續貢獻收益。- 為打造多品類及風格多樣的遊戲組合,集團預期於2024年下半年至2026年期間在全球各地推出7款不同類型的遊戲產品,其中包括一款由虛幻引擎4打造的、根據《龍族》系列小說和動畫改編及開發的策略卡牌類手遊《龍族:卡塞爾之門》,一款由虛幻引擎4打造的中國風放置RPG手遊《踏風行》,以及一款依託虛幻引擎5 打造的、根據《龍族》系列小說改編的MMORPG+遊戲項目代號:Odin。香港, 2024年8月24日 - (亞太商訊 via SeaPRwire.com) — 祖龍娛樂有限公司(「祖龍娛樂」或「公司」,連同其附屬公司,統稱「集團」,股份代號:9990.HK)公佈其截至2024年6月30日止六個月(「報告期內」)之未經審核中期業績。2024年上半年,祖龍娛樂錄得收益人民幣439.4百萬元,較截至2023年同期人民幣402.3百萬元增加9.2%,主要由於《以閃亮之名》以高超的產品質量樹立了優秀的口碑並吸引了大量的玩家;其中,綜合遊戲發行及運營業務收益為人民幣376.5百萬元,較2023年同期增加25.0%,佔總收益的85.7%。2024年上半年,集團毛利同比增加8.1%至人民幣321.7百萬元;毛利率為73.2%,与去年同期基本持平。報告期內,集團研發開支同比減少11.7%至人民幣264.1百萬元,銷售及營銷開支同比小幅增加5.0%至人民幣172.7百萬元。受益於上述因素,2024年上半年集團經調整虧損淨額為人民幣120.4百萬元,較2023年同期大幅收窄44.0%。《以閃亮之名》領跑女性向賽道 精細化運營強化長線生態《以閃亮之名》是一款以公司新一代女性製作和策劃團隊為核心研發的超自由時尚女性向手遊,自2023年3月24日首次上線中國大陸地區以來,十餘次衝入iOS遊戲暢銷榜前十名。該遊戲於中國大陸地區上線週年之際開啟系列慶祝活動:2024年3月24日在上海、紐約、墨爾本等全球五地標誌性展示屏上同步宣傳《以閃亮之名》,當日登頂微博熱搜第一名;4月3日上線週年慶版本「夢狐繪卷」,當日流水即超過人民幣2,000萬元,並衝進中國大陸iOS遊戲暢銷榜前十名。在陸續推出的活動中,遊戲亦融入了例如蜀繡、泉州提線木偶戲、德化白瓷、京劇等中國非物質文化遺產定制內容,在滿足玩家個性化需求的同時更向不同地區大眾展示出中國傳統藝術無與倫比的魅力。此外,遊戲於上半年上線了寵物系統,目前開放大地圖也正在積極推進中,未來亦將解鎖更多的新玩法。依託成熟高效的研發及運營管理定期上線更新活動,以及憑藉高超的產品質量樹立的優秀口碑和吸引的大量玩家,《以閃亮之名》這種良好的發展模式勢必將為集團帶來積極可觀的長線收益。截至2024年6月30日,《以閃亮之名》的全球累計用戶數超過1,600萬。《三國群英傳:鴻鵠霸業》是一款基於《三國群英傳》IP打造的SLG遊戲,已於7月13日通過授權發行方式在中國大陸地區正式上線,並計劃於第四季度在中國港澳台地區上線。該遊戲在繼承了《鴻圖之下》核心優勢的同時豐富了差異化的玩法,並通過優化福利體系,提升了用戶的體驗和留存。基於SLG品類遊戲產品的長線運營特徵,以及授權代理商穩扎穩打的發行風格,該款遊戲的數據表現正在穩健增長中。與此同時,對於《龍族幻想》、《鴻圖之下》、《夢幻誅仙》、《萬王之王3D》、《御劍情緣》、《六龍爭霸》等多款在運營中的經典遊戲,公司持續進行運營投入,通過週年慶、版本更新等活動維護遊戲健康的長線生態,各款遊戲表現相對穩定並為集團持續貢獻收益。多品類佈局優化產品矩陣 精品化戰略注入發展動能為打造多品類及風格多樣的遊戲組合,集團預期於2024年下半年至2026年期間在全球各地推出7款包括MMORPG+、策略卡牌及放置RPG等不同類型的遊戲產品。其中,兩款由虛幻引擎4打造的重磅精品遊戲《龍族:卡塞爾之門》和《踏風行》均計劃於2024年下半年上線,預期將持續豐富集團的產品矩陣。《龍族:卡塞爾之門》是一款根據《龍族》系列小說和動畫改編及開發的策略卡牌類遊戲,計劃主要採用自主發行方式,已於2024年5月及7月開啟兩次付費測試,並計劃於9月正式上線;《踏風行》是一款中國風放置RPG手遊,計劃主要採用自主發行方式,已於6月開展國服首次付費測試,並將力爭於今年年內正式上線。此外,依託虛幻引擎5 打造的MMORPG+遊戲項目代號:Odin正在有序開發中。該遊戲根據《龍族》系列小說改編,是集團使用革新技術對經典IP深度開發的誠意之作,希望能在優勢MMO賽道中呈現遊戲的精神內核,將極致的美術效果和遊玩體驗呈現給全球玩家。該遊戲預期將於2025年上線。日後,隨著產品類型由MMORPG、SLG、女性向擴張至策略卡牌、放置RPG等多品類和豐富多樣的風格,及不斷完善「研運一體」的有機模式,預期公司遊戲的生命週期將進一步延長,這將對公司收益作出更穩定及持續的貢獻。技術革新帶動產品力提升 研運一體及全球化戰略鞏固競爭優勢作為在業內率先研究和使用虛幻引擎開發移動遊戲的遊戲廠商,祖龍娛樂立足於手機移動端遊戲,積極進行PC端、Steam等多平台、多渠道版本的拓展,致力於讓更廣泛的玩家獲得優質精良的遊戲產品。與此同時,公司針對移動端全動態光源陰影和自研全局光照等方面進行專項突破,使得遊戲在性能和視覺效果上進一步升級。展望未來,祖龍娛樂將繼續加強對研運一體及全球化戰略的佈局,在加強對長線運營投入的同時,持續在不同國家及地區輸出高質量產品。此外,集團亦將不斷開發各品類領先的精品遊戲,使創新和好玩進行有機結合,進一步回歸做遊戲的本質和初心,為全球玩家創造卓越的在線娛樂體驗。-完-關於祖龍娛樂有限公司祖龍娛樂是中國手遊行業的開拓者,專注於開發優質MMORPG、SLG、女性向、策略卡牌及其他類型的手遊,開發優質手遊的實力屢經驗證,且注重核心遊戲性體驗品類的持續深耕。截至2024年6月30日,祖龍娛樂在逾170個地區市場共推出21款精品手遊,支持14種語言的多個地區版本,所提供的高質量的多元遊戲組合擁有良好的市場聲譽。 Copyright 2024 亞太商訊 via SeaPRwire.com.
More
福壽園2024年上半年在服務延展、科技引領、文化創新等領域多點發力 ACN Newswire

福壽園2024年上半年在服務延展、科技引領、文化創新等領域多點發力

香港, 2024年8月24日 - (亞太商訊 via SeaPRwire.com) — 中國領先的殯葬服務提供商--福壽園國際集團有限公司(「福壽園」或「公司」,連同其附屬公司,統稱「集團」;股份代號:1448.HK)公佈截至2024年6月30日止六個月 (「回顧期內」) 之中期業績。2024年上半年,中國經濟整體穩定運行,長期向好。隨著中國全面步入小康社會,站在了新的歷史起點上,推動民生福祉達到新水準、不斷增強人民群眾獲得感、幸福感、安全感將是中國在民生領域未來發展的主要目標。進入了新時代,人民群眾對美好生活的嚮往從「生」延伸到「死」,提升人民群眾身後事的服務質量、實現「逝有所安」已成為殯葬領域重大時代課題,並不斷推動中國殯葬行業向縱深發展。回顧期內,為應對經濟大環境和客戶消費行為的相應變化趨勢,集團從市場和產品的雙重維度持續關注,在服務延展、科技引領、文化創新等領域多點發力,因「園」施策,著力滿足墓園客戶多元化、差異化,特別是精神層面的消費需求,持續提升產品和服務的核心競爭力,實現集團長期可持續發展。2024上半年,本集團總收益達人民幣1100百萬元,公司擁有人應佔溢利及全面收入達人民幣299百萬元。董事會擬向股東派發2024年中期股息每股6.38港仙,符合本集團所承諾的派息政策,以答謝股東一直以來的支持和肯定。回顧期內,集團在公益事業、公共關係、科技創新、品牌發展方面的表現獲得社會各界認可,先後獲得第十屆亞洲微電影藝術節「金海棠獎」、上海市優秀公關案例評選銀獎、第十三屆公益節「年度教育公益貢獻獎」、第八屆中國公益年會「年度中國公益企業」等榮譽。特別是在二零二四品牌強國論壇上,福壽園憑藉30年來在品牌建設方面的創新成果,經相關部門及媒體推薦,與華為技術、國家電網、騰訊科技、阿里巴巴、抖音等共同入圍「二零二四中國創新品牌500強」,福壽園品牌價值獲評價人民幣139.95億元,品牌指數高達431.64分,排名第233位。截至目前,集團的業務已進入十九個省、自治區、直轄市的四十餘座城市,包括上海、河南、重慶、安徽、山東、遼寧、黑龍江、福建、浙江、江西、江蘇、廣西、北京、貴州、內蒙古、甘肅、湖北、河北及陝西,其中包括正在運營的位於全國十七個省的主要城市、直轄市和自治區的墓園和殯儀設施。集團在全國其他重要省份、省會城市及空白區域的拓展計畫仍在穩步推進中。集團將以審慎和穩健的步伐,堅守對股東負責的態度,篩選合適的目標,整合多元業務資源,以公允合理的對價收購優質資產。向生命科技服務提供者轉型 墓園業務領域具有競爭力集團正在從行業領先的殯葬綜合服務商轉型為生命科技服務提供者,持續致力於落實「3JI」理念(記號做美,記載做厚,紀念做長)在各地、各墓園的應用。本期間內,在「3JI」理念的導引下,我們推出了墓穴產品+服務的新情緒整合產品,致力於為生命提供創新、藝術和更多維度的服務與滿足。截至目前,以「3J」理念設計並成功落地的17家墓園園區,藝術美學得到了深刻的表達,從飽含人文關懷態度的設計理念到內外兼修的園區整體構造,從作為修飾性的自然景觀到功能性和藝術性共存的碑體形態,對生命的敬畏和對生命美學的追求均得以彰顯。此外,通過本期間「3JI」產品的多點運行,市場和客戶的體驗回饋令我們鼓舞和興奮,集團相信「3JI」理念下產品和服務的應用將不斷強化本集團墓園產品的核心競爭力,觸動客戶的需求點,助推下半年墓園業務銷量的提升。上半年,在國內建築行業整體下行的大環境下,集團設計板塊的全資子公司天泉佳境專注殯葬領域的規劃設計,仍保持了較為穩定的經營和發展,經營業績及新簽項目合同額較二零二三年同期均有增長。天泉佳境通過市場公開招標在本期間獲得多地殯葬設施的規劃設計業務,其設計實力及經營能力在國內仍保持領先地位。同時,在集團內部,天泉佳境積極踐行「3JI」理念,為集團各實體公司的「3JI」規劃與落地,提供了強有力的保障,進一步增強集團產品在市場上的競爭力。激發業務活力 實現殯儀業新消費需求回顧期內,集團著重在業務結構調整、客戶價值創造、禮儀服務轉型和科技賦能管理幾個方面開展工作。通過以「新場景、新用品、新服務」為主的核心流程改造,實現現代殯儀的「新消費」需求,激發傳統殯儀業務的活力,滿足市場差異化、多元化的服務需求,引領行業發展。公司充分關注客戶心理需求,利用智慧聲光系統改造火化場景,將「冥想療癒」服務引入告別儀式;研發安靈接運儀式及相關文創產品,提升客戶對殯儀服務的體驗感和獲得感。同時,進一步擴大殯儀用品集中研發和集中採購範圍,將「文化紙棺」、「文化靈盒」、「隨行香囊」等嵌入到儀式中,確保殯儀「新文化」全覆蓋。此外,集團持續推進技術含量高,如防腐和古人沐浴等高附加值服務的推廣,強化自身的核心競爭力,助推殯儀服務高品質可持續發展。在人口老齡化的社會背景下,生前契約服務正吸引更多希望儘早安排好自己身後事的客戶群,亦得到各級政府及長者服務機構的肯定、支援和服務採購。本期間內,累計簽訂生前契約11,923份合約(2023年同期:9,272份合約),較上年同期增長28.6%。銷量的主要增長來自於機構、政府的解決方案的採購以及來源於制定不同目標層次的產品。自主研發環保智慧火化設備 全方位服務客戶集團的環保火化機業務集研發設計、自主生產、全面配套及售後服務為一體,生產智慧環保火化設備及尾氣淨化處理系統。上半年,集團繼續優化產品性能,持續收集客戶回饋,進一步提高產品品質,降低運維成本。積極維持國內外客戶,做好售前技術支持、售後維修保障工作,研發並提供了舊式JS-2火化爐更新改造服務,以使得現有客戶可以分享最新的產品升級和能耗節約成果。同時,集團持續對新型揀灰爐、尾氣淨化系統設備進行資料統計分析驗證,不斷優化調整,進一步降低火化時長和燃料消耗。此外,亦在建立環保火化設備板塊自身的國內外銷售體系。集團亦與國內外多家潛在合作方保持密切聯繫,亦與多家簽訂了數台火化機、尾氣系統和若干輔助設備的銷售合作協定。隨著新型城鎮化進程推進後相應殯葬設施的建設、人口老齡化趨勢和遺體火化率提升的加速,相信各地對環保智慧火化設備的需求將大幅增長。福壽園國際集團有限公司董事局主席兼執行董事白曉江先生表示:「福壽園持續秉承「以人為本、文化為根」的理念,正在從行業領先的殯葬綜合服務商轉型為生命科技服務提供者,從物理世界「福壽園」向精神世界「福壽元」發展。致力於把「記號做美,記載做厚,紀念做長」。」-完-此新聞稿由博達浩華國際財經傳訊集團代福壽園國際集團有限公司發佈。如有垂詢,請聯絡:馮嘉莉 / 王佩電話:+852 3150 6788電郵:fsy@pordahavas.com Copyright 2024 亞太商訊 via SeaPRwire.com.
More

企展控股宣佈二零二四年中期業績

財務摘要:- 收益約人民幣127,590,000元,同比增長333.5%;- 毛利約人民幣33,272,000元,同比增長214.8%;- 純利約人民幣19,097,000元,同比增長307.9%;- 期末現金及現金等價物約為人民幣208,678,000元。香港, 2024年8月24日 - (亞太商訊 via SeaPRwire.com) — 企展控股有限公司(「企展控股」或「公司」;股份代號:1808.HK)宣佈公司及其附屬公司(「集團」)截至二零二四年六月三十日止六個月之未經審核中期業績。二零二四年上半年,集團把握數字經濟浪潮下的行業發展機遇,穩步拓展原有業務,同時加快佈局新質生產力發展,積極開闢新業務賽道,以創新為引領,穩中求進,業務佈局和發展已初顯成效並取得了階段性成果。本期間,集團錄得收益約人民幣127,590,000元,同比增長333.5%;毛利約人民幣33,272,000元,同比增長214.8%;純利約人民幣19,097,000元,同比增長307.9%;軟件業務突飛猛進,驅動長期內生增長隨著數據要素市場快速發展,數據基礎制度體系日臻完善,數據資產成為經濟社會數字化轉型過程中的新興資產類型,正日益推動數字中國建設,是加快數字經濟發展的重要戰略資源。在此背景下,集團力争把握機遇,持續發展現有業務,充分發揮多年累積的客戶資源和產品服務優勢固本強基,同時主動佈局由前沿科學技術突破、生產要素創新配置和產業轉型升級等要素共同催化促進的新質生產力發展,特別是在以數據、智算與邊緣計算、網絡、應用為核心要素的數字經濟領域。回顧二零二四年上半年,集團穩中求進,优化業務格局已經初見成效,業務較二零二三年同期顯著增長,呈現出高成長性,推動整體收益大幅增加,並為集團長期內生增長奠定了堅實的基礎。本期間,集團軟件維護及其他服務錄得收益約人民幣49,347,000元,同比增長172.6%,收入占比約39%;軟件產品及其他產品銷售錄得收益約人民幣78,243,000元,同比增長590.4%,收入占比約61%。深耕產業鏈一體化,加快業務創新升级為推動長遠可持續發展,在實施路徑方面,集團將以業務為導向,打通並構建「三鏈一圈」,專注於創新鏈、產業鏈、金融鏈的整體協同。同時,通過業務模式創新化、數據要素資產化、投資、孵化成果資本化、產業佈局生態化四個方面的有機組合,不斷鞏固創新驅動和開放共贏的數字經濟領域生態圈。在市場拓展方面,集團將搶抓政策機遇,搶佔市場先機,通過深化技術創新、優化服務模式、拓展應用場景,齊頭並進多條線開拓市場,提高市場佔有率,促進企業持續增長,鞏固行業領先地位。此外,還將進一步加強發展與行業內外夥伴的合作,構建一個開放、共贏的生態系統,以確保在市場環境快速變化時,能夠持續保持其競爭力和創新力。未來展望二零二四年下半年,集團將持續鍛長補短,優化、鞏固自身在數據要素、數據資產運營、智算與邊緣計算領域的先發優勢,充分釋放產業鏈集聚效應,在產業鏈一體化和產業生態建設中不斷耕耘,持續推動業務創新升級,致力於將自己打造成為專注於數字經濟領域,聚焦數據要素、數據資產運營和人工智能智算與邊緣計算,為客戶提供數字科技集成解決方案的服務供應商,為股東創造更高價值。集團執行董事及聯席行政總裁梁亮表示,「數字經濟行業正處於快速發展的階段,展現出了強大動能和市場潛力。為更好繪製公司未來發展第二曲線,我們期望積極聯合生態夥伴,設立數字科技產業鏈投資平台,雙鏈路賦能產業生態各節點,通過產業孵化投資等方式,發揮大數據、大模型、大算力的技術潛力,促進數字與實體的融合,共建和諧產業生態,促進多方互利共贏」。-完- Copyright 2024 亞太商訊 via SeaPRwire.com.
More
2nd ASEAN Battery Technology Conference Strengthens Southeast Asia Battery Ecosystem Through New Collaborations and Expansion ACN Newswire

2nd ASEAN Battery Technology Conference Strengthens Southeast Asia Battery Ecosystem Through New Collaborations and Expansion

SINGAPORE, Aug 24, 2024 - (ACN Newswire via SeaPRwire.com) - The 2nd ASEAN Battery Technology Conference (ABTC) returned and strengthened the commitment to develop a close knitted battery development ecosystem among the Southeast Asian countries. Hosted in Singapore this year by the Singapore Battery Consortium at Singapore at the Shangri-La Rasa Sentosa between 21st and 23rd August 2024.The conference is also jointly organised by the alliance of leading battery related associations in the region - the Thailand Energy Storage Technology Association, the National Battery Research Institute, the National Center for Sustainable Transportation Technology, NanoMalaysia, and the Electric Vehicle Association of the Philippines.Dr. Pimpa Limthongkul, Co-Chairman of ABTC and President of the Thailand Energy Storage Technology Association, said, "This year, we are excited to see the expansion of what we have achieved since we last gathered together last year in Bali. Our alliance has grown from three to now six battery associations in Southeast Asia and we will continue to grow in strength. Witnessing the collaborations between the battery associations, private sector and academia is a celebration of how we are moving forward together to drive innovation for a more connected and eco-friendly future in the region.”On the second day of the conference, over 250 participants and the six leading battery associations in Southeast Asia witnessed the signing of three new Memorandums of Understanding or MoUs that will further the development of batteries in the region.From L to R: Prof. Nonglak Meethong (Professor, Khon Kaen University), Mr. Larry Poon (Business Development Manager, INV CORPORATION PTE. LTD.), Dr. Rezal Khairi Bin Ahmad (CEO, NanoMalaysia Berhad), Mr. Bryan Oh (CEO, NEU Battery Materials Pte Ltd) Mr. Freddie Kim (Managing Director, SAMSUNG SDI SOUTHEAST ASIA), Dr. Sing Yang Chiam, Technical Director Singapore Battery Consortium.Three Memorandums of UnderstandingGigafactory Malaysia (GMSB) and NEU Battery Materials (NEU) to Collaborate on Lithium Battery Recycling DevelopmentThe collaboration will focus on developing “Gigafactory” level operations and manufacturing of innovative battery technologies incorporating nanomaterials for mobility and stationary applications. This collaboration is the progression of the Memorandum of Understanding (“Memorandum”) signed in Bali, Indonesia at the 2023 ASEAN Battery and Electric Vehicle Technology Conference (ABEVTC) to promote cross-country collaboration within ASEAN on battery technology.Singapore-based, NEU, who are specialists in LFP battery recycling will ensure a steady supply of recycled battery material, like lithium carbonate and other metals are made available to GMSB’s Hydrogen-Electric-Vehicle-Battery (HEBATT) Centre for performance testing. GMSB is a subsidiary of NanoMalaysia.The testing of the recycled material is to ensure their viability and sustainability within the Malaysia battery ecosystem, which would expand to localised development of a lithium battery recycling ecosystem for the ASEAN region. NEU and GMSB will facilitate this supply and development based on spent battery material being used in an end-to-end ecosystem.This will also pave the way for the exploration of a joint-development programme for improved recycling efficiency between these two companies.Gigafactory Malaysia Sdn Bhd (GMSB) and Khon Khean University (KKU) to Collaborate on Manufacturing of Cells Developed by GMSBGMSB’s and KKU’s collaboration will leverage their joint expertise and resources, with KKU acting as the outsourced manufacturer for batteries developed by GMSB. The collaboration will also provide knowledge sharing in battery testing and certification that will lead to productivity advancements at GMSB's Hydrogen-Electric-Vehicle-Battery (HEBATT) Centre in Malaysia.This Memorandum of Understanding (MoU) is an extension of an agreement signed at the 2023 ASEAN Battery and Electric Vehicle Technology Conference (ABEVTC) in Bali, which involved key organisations from Singapore, Indonesia, Thailand, Malaysia, and the Philippines.Aligned with the ASEAN Battery Network's mission, this MoU aims to strengthen battery technology development within ASEAN.Institute of Materials Research and Engineering (IMRE), Singapore and INV Corporation to collaborate on Joint Research to Develop Hybrid Battery SeparatorsA Research Collaborative Agreement will be signed between the Institute of Materials Research and Engineering in Singapore and INV to develop the next generation hybrid battery separators, which will address the challenges of safety faced by current rechargeable batteries.This collaboration seeks to play on the strengths and IPs in solid state batteries developed in Singapore. INV is headquartered in Singapore and is the largest battery separator film manufacturer in the world. Its production plants are in Sweden and Malaysia.Samsung SDI Southeast Asia ExpansionSamsung SDI, a high-performance battery manufacturer based in South Korea, opened its Regional HQ in Southeast Asia in Singapore on 19 April 2024. Samsung SDI currently has two manufacturing sites in Southeast Asia, located in Malaysia and Vietnam. To enhance customer service, the company has established two sales offices in Vietnam (December 2023) and Singapore (April 2024).Samsung SDI Southeast Asia PTE LTD (SDISEA) also announced that it will open Samsung SDI R&D Singapore (SDIRS) on 1 September 2024, during the 2nd ASEAN Battery Technology Conference (ABTC).Under its vision of making the world greener and more sustainable through innovative technology, Samsung SDI will provide its customers in Southeast Asia with PRiMX (Prime Battery for Maximum Experience) batteries and technologies in pursuit of utmost customer satisfaction.Hosting of the ABTC is rotated among the co-organisers. In 2025, TESTA will host the ABTC in Thailand.For more information on the programme agenda, please visit our official site: https://reg.eventnook.com/event/ABTC2024/homeThe conference's anchor sponsor is Hyundai Motor Group Innovation Center Singapore (HMGICS), with the gala dinner sponsored by INV Corporation Pte Ltd.Gold sponsors include Amphenol Communications Solutions, Quantel Pte Ltd, Infineon Technologies Asia Pacific Pte Ltd, and Gotion Singapore Pte Ltd, while silver sponsors are Concord New Energy Group Limited, Kewell Technology Co.,Ltd., Metrohm Singapore Pte Ltd, TME Systems Pte Ltd.Additional sponsors include Samsung SDI Southeast Asia Pte. Ltd, Siemens Industry Software Pte Ltd, UL Standards & Engagement, and NEWARE Technology Limited. Publicity partners are the EV Association of Singapore, EV Association of Malaysia, and Turn Off Turn On Ventures.Media ContactPRecious Communicationsabtc@preciouscomms.comAbout ASEAN Battery Technology ConferenceASEAN Battery Technology Conference (ABTC) stands out as the premier battery conference in ASEAN, attracting an audience of over 250 participants. We look forward to engaging with a diverse range of participants, including cell manufacturers, pack integrators, and recycling companies. The mission of ABTC is to bring together regional battery expertise, creating unique opportunities within the global battery value chain.The primary objective of ABTC is to foster collaboration among stakeholders in the battery industry. We aim to facilitate insightful discussions covering various topics, such as advanced battery materials, prototyping, cell-to-pack technologies, and recycling strategies.In addition to these focal points, the conference will explore related aspects such as standards, interoperability, and the ongoing evolution of battery safety technology.Organisers of ABTCAbout Singapore Battery ConsortiumSingapore Battery Consortium (SBC) aims to foster strategic R&D partnerships amongst public research performers and industry players in developing and advancing battery technologies. SBC aims to develop and catalyze the local ecosystem in battery-related technologies through this platform. It is hosted at A*STAR and supported by the National Research Foundation Singapore (NRF). Over the past decade, commercial interest in battery development has been on the rise, keeping pace with demand for better battery performance and different performance characteristics for increasingly complex mobility and portable devices. To meet this demand, the Singapore Battery Consortium will bring research outcomes from our laboratories into the market by enabling researchers to understand business requirements, while giving companies access to the latest battery research and technologies to augment their product development efforts.About Thailand Energy Storage Technology Association (TESTA)TESTA or THAILAND ENERGY STORAGE TECHNOLOGY ASSOCIATION aims to help connect stakeholders, educate the public, promote understanding, and nurture technological advancements in energy storage technologies in Thailand. TESTA was officially registered on January 25, 2021, by 5 founding institutes including the National Science and Technology Development Agency (NSTDA), Khon Kaen University (KKU), King Mongkut’s University of Technology Thonburi (KMUTT), King Mongkut’s University of Technology North Bangkok (KMUT-NB), and Electric Vehicle Association of Thailand (EVAT). Over 60 members of the association include energy storage technology enthusiasts from various sectors ranging from academic, research institutes, public sectors, policymakers, and private industries.About National Center for Sustainable Transportation Technology (NCSTT)The National Center for Sustainable Transportation Technology (NCSTT), or Pusat Pengembangan Teknologi Transportasi Berkelanjutan, is from Indonesia and is a unique multidisciplinary research center focused on conducting, supporting and encouraging applied engineering and technology for transportation systems in Indonesia. NCSTT has been recognized globally as the research center which aims to foster the national transportation industry in developing national economics and welfare. NCSTT has built network linkages and research collaborations with national transportation stakeholders such as automotive, railway and aircraft industries, as well as research institutions and universities.About National Battery Research Institute (NBRI)The National Battery Research Institute (NBRI) was legally established on 17th December 2020 as The Center of Excellence Innovation of Battery and Renewable Energy Foundation, with Prof.Dr. Evvy Kartini as a Founder and Prof Alan J. Drew as Co-Founder. NBRI is Indonesia’s independent institute for electrochemical energy storage science and technology, supporting research, training, and education. NBRI aims to contribute to the overall research capacity and training environment in Indonesia in Battery Research. NBRI is a platform that brings together scientists, academicians, industry partners, the government and all stakeholders that focus on battery technology. The main goal of NBRI is to encourage and support a battery manufacturing industry using local resources, which will enable Indonesia to be independent in energy. The NBRI was supported by the UK Government’s Global Challenge Research Fund (GCRF), part of the Queen Mary University of London QR allocation.About Electric Vehicle Association of Philippines (eVAP)eVAP envisions a nation wherein the use of electric vehicles is highly promoted, encouraged and supported by its government and society to develop a transportation landscape that is one with the environment ecologically and economically. eVAP’s mission is to educate the public on environmental awareness, and the economic and ecological benefits of electric vehicles through the conduct of and/or participation in promotional activities.eVAP aims to accelerate society’s conversion from using gas-powered vehicles to electric vehicles and works with the government in the creation and implementation of legislation that will support and encourage the use of electric vehicles.About NanoMalaysiaNanoMalaysia Berhad was incorporated in 2011 as a company limited by guarantee (CLBG) under the Minister of Science, Technology and Innovation (MOSTI) to act as a business entity entrusted with nanotechnology commercialization activities. Some of its roles include commercialization of nanotechnology research and development, industrialization of nanotechnology, facilitation of investments in nanotechnology and human capital development in nanotechnology. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Kyrgyzstan Education Ministry Partners Singapore’s Marshall Cavendish Education with Plans to Adopt Singapore Maths and Science Education Titles in the Country ACN Newswire

Kyrgyzstan Education Ministry Partners Singapore’s Marshall Cavendish Education with Plans to Adopt Singapore Maths and Science Education Titles in the Country

ISSYK KUL, Kyrgyzstan, Aug 24, 2024 - (ACN Newswire via SeaPRwire.com) - The Ministry of Education and Science of the Kyrgyz Republic has partnered with Singapore's Marshall Cavendish Education (MCE) to introduce key training programmes and education resources to its schools throughout the country. The partnership seeks to instill key skillsets and content knowledge to strengthen teachers and students' abilities for the 21 st century.Kyrgyzstan is set to implement significant shifts in the hopes of increasing the educational quality and to increase the number of children that attend schools. The new titles by MCE will become available to over 2000 public schools and over 1.4 million students in the country. [1]Marshall Cavendish Education's English, Mathematics and Science series from kindergarten to grades 1 till 11 will soon be available in the local languages in Kyrgyzstan with its recent partnership with Okuu Kitebi Publishing House. Alongside the new syllabus and resources, MCE is set to conduct training and mentoring programmes that aim to support the Programme for International Student Assessment (PISA) competencies of teachers and students in subjects such as Mathematics and Science. Veteran educators from Singapore will present modules to help local educators and master trainers understand key concepts such as problem-solving skills and scientific inquiry, ultimately working towards inculcating a nationwide movement to achieve an improved and sustained academic performance regionally and internationally. The partnership will also include the introduction of artificial intelligence platform Cerebry, an engine and digital platform for teachers to integrate technology within their classrooms and enhance the learning experiences of the students. Unique questions and solutions are generated on demand, for each individual student.The launch of the partnership hosted at Issyk Kul, one of the deepest lakes in the world, saw more than 200 attendees who are key stakeholders in Kyrgyzstan's education ministry. It was also attended by Deputy Prime Minister Edil Baisalov, Minister of Education and Science of Kyrgyz Republic, Dogdurkul Kendirbaeva, UNICEF Representative to the Kyrgyz Republic, Samman J. Thapa and CEO, Times Publishing Limited Siew Peng Yim."In this partnership, our key goal is to provide a strong and consistent support and motivation to our educators in Kyrgyzstan. Singapore had faced tremendous challenges in its journey to achieve success in creating a world class education ecosystem. Marshall Cavendish Education will use the lessons we had learnt from the Singapore education transformation journey to provide the necessary resources and we will also tailor-made our solutions for Kyrgyzstan to help your students to achieve academic success and more importantly to build their confidence and to enjoy learning once more," shared Mr. Siew Peng Yim, CEO, Times Publishing Limited."The books published by Marshall Cavendish Education, which over its 60-year history have established collaborations with more than 90 countries and have been translated into 17 languages, are now available to us. We believe that the books they have published contributed to the journey Singapore has had with its education. After selecting, analyzing, and studying samples from many countries, we have decided to partner with MCE. We are ready to collaborate and aim for the partnership to bring Singapore educators to share their expertise on the education system" said Ms Dogdurkul Kendirbaeva, Minister of Education and Science of Kyrgyz Republic.About Marshall Cavendish EducationMarshall Cavendish Education (MCE) is a global education solutions provider dedicated to nurturing the joy of learning and preparing students for the future. We believe the best way to do so is by simplifying learning and listening to the needs of schools, teachers, students, and parents. MCE makes world-class educational content more accessible through a seamless experience that integrates both print and digital resources. We provide holistic and end-to-end solutions customised to the school's requirements, with professional development to help educators implement the curriculum. We've worked with ministries, policymakers, educators, and parents in over 90 countries, designing education solutions in 14 languages for Pre-K to 12. MCE is the only Asia-based publisher that is an endorsement partner of Cambridge International Education.www.mceducation.comFor Media Enquiries:Shahidah HamsahName:shahidahhamsah@mceducation.com[1] https://www.unicef.org/kyrgyzstan/media/8021/file/Education%20Joint%20Sector%20Review.pdfSOURCE: Marshall Cavendish Education Pte Ltd Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna’s COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1 ACN Newswire

Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna’s COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1

Cambridge, MA, Aug 24, 2024 - (ACN Newswire via SeaPRwire.com) - Moderna, Inc. (NASDAQ:MRNA) today announced that it has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for a partial change application for an updated formulation of its COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.1."We appreciate the Ministry of Health, Labour and Welfare approval decision for our updated COVID-19 mRNA vaccine," said Stéphane Bancel, Chief Executive Officer of Moderna. "It is important that people are vaccinated with the latest updated COVID-19 vaccines that can protect against circulating strains. With COVID-19 vaccination becoming a routine inoculation similar to seasonal flu vaccines, individuals will be able to receive their updated COVID-19 vaccine alongside their flu vaccine this fall."In May 2024, a Japanese health ministry panel recommended that COVID-19 vaccines be updated to target the JN.1 family of Omicron subvariants for the 2024/2025 national immunization program (NIP). This guidance aligns with the recommendations from the World Health Organization (WHO) Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) on the use of a monovalent JN.1 lineage for COVID-19 vaccine antigen composition.The NIP in Japan will offer COVID-19 vaccination to individuals aged 65 and older, as well as qualifying individuals aged 60 to 64.[1] Japan has the highest proportion of older adults worldwide, with approximately 30% of its population aged 65 and above. Given that respiratory viruses are a leading disease burden in people older than 65, NIPs are crucial in reducing the burden of disease and, ultimately, future pressure on the health system. Individuals requesting COVID-19 vaccination outside of the regular program will have the option of voluntary vaccination at their own expense.In July, Moderna entered into an agreement with Mitsubishi Tanabe Pharma Corporation to support the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including Moderna's COVID-19 vaccine, Spikevax.About ModernaModerna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.Moderna Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: the authorization of Moderna's updated JN.1-targeting COVID-19 vaccine by the Ministry of Health Labor and Welfare in Japan; the ability of Moderna's updated COVID-19 vaccine to induce an immune response and provide protection against circulating SARS-CoV-2 variants; and Moderna's ability to supply its COVID-19 vaccine to support Japan's COVID-19 national immunization program. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna's control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading "Risk Factors" in Moderna's Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC's website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna's current expectations and speak only as of the date of this press release.Moderna ContactsMedia :International mediaLuke Mircea-WillatsSenior Director, International CommunicationsLuke.mirceawillats@modernatx.comModerna JapanCommunications & Mediajapan-pr@modernatx.comInvestors:Lavina TalukdarSenior Vice President & Head of Investor Relations+1 617-209-5834Lavina.Talukdar@modernatx.com[1]Qualifying individuals include those aged 60-64 with severe cardiac, renal or respiratory impairments that significantly restrict daily activities, or those with immune deficiencies due to Human Immunodeficiency Virus (HIV), making daily life exceedingly difficult.SOURCE: Moderna, Inc. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
吉爾吉斯斯坦教育部與新加坡Marshall Cavendish教育公司合作,計劃在該國採用新加坡數學和科學教育教材 ACN Newswire

吉爾吉斯斯坦教育部與新加坡Marshall Cavendish教育公司合作,計劃在該國採用新加坡數學和科學教育教材

吉爾吉斯斯坦伊塞克湖, 2024年8月24日 - (亞太商訊 via SeaPRwire.com) - 吉爾吉斯共和國教育與科學部與新加坡Marshall Cavendish教育公司(MCE)合作,向全國各地的學校引入關鍵的培訓項目和教育資源。此次合作旨在培養關鍵技能和知識內容,以增強教師和學生在21世紀的能力。吉爾吉斯斯坦將實施重大變革,旨在提高教育質量並增加入學兒童人數。通過MCE的新教材,超過2000所公立學校和140多萬名學生將受益。[1]MCE的英語、數學和科學系列教材將從幼兒園到1至11年級,隨著與Okuu Kitebi出版社的合作,逐步在吉爾吉斯斯坦以當地語言推出。除了新課程和資源,MCE還將開展培訓和指導項目,旨在支持教師和學生在數學和科學等科目中的國際學生評估項目(PISA)能力。來自新加坡的資深教育工作者將提供模塊,幫助當地教育工作者和主培訓師理解關鍵概念,如問題解決技能和科學探究,最終推動全國範圍內實現更好和持續的地區及國際學術表現。此次合作還將引入人工智慧平台Cerebry,一個供教師在課堂中整合技術、增強學生學習體驗的引擎和數位平台。該平台能夠根據需求,為每個學生生成獨特的問題和解決方案。**在世界最深的湖泊之一伊塞克湖舉辦的合作啟動儀式上,吸引了200多位吉爾吉斯斯坦教育部的重要利益相關者出席。吉爾吉斯斯坦副總理Edil Baisalov、教育與科學部長Dogdurkul Kendirbaeva、聯合國兒童基金會(UNICEF)駐吉爾吉斯斯坦代表Samman J. Thapa,以及時報出版有限公司首席執行官Siew Peng Yim也出席了此次活動。 “在這次合作中,我們的主要目標是為吉爾吉斯斯坦的教育工作者提供強有力且持續的支持和激勵。新加坡在實現創建世界一流教育生態系統的過程中,面臨了巨大的挑戰。Marshall Cavendish教育公司將利用我們在新加坡教育改革過程中學到的經驗,提供必要的資源,並且我們還將為吉爾吉斯斯坦量身定制解決方案,幫助學生取得學業上的成功,更重要的是重建他們的自信心,並重新享受學習的樂趣,”時報出版有限公司首席執行官Siew Peng Yim說道。 “Marshall Cavendish教育公司在其60年的歷史中,已與90多個國家建立合作關係,出版的書籍已被翻譯成17種語言,現在這些書籍已經為我們所用。我們相信,他們出版的書籍為新加坡的教育發展作出了貢獻。經過對多個國家的樣本進行挑選、分析和研究後,我們決定與MCE合作。我們準備好合作,並期待這一合作能夠使新加坡教育工作者分享他們在教育系統方面的專業知識,”吉爾吉斯斯坦教育與科學部長Dogdurkul Kendirbaeva說道。**關於Marshall Cavendish教育公司 Marshall Cavendish教育公司(MCE)是一家全球教育解決方案提供商,致力於培養學習的樂趣,並為學生的未來做好準備。我們相信,最好的方法是簡化學習,並傾聽學校、教師、學生和家長的需求。MCE通過整合印刷和數位資源的無縫體驗,使世界級的教育內容更加易於獲取。我們提供整體和端到端的解決方案,定制化滿足學校的需求,並提供專業發展支持,幫助教育工作者實施課程。我們已與90多個國家的教育部、政策制定者、教育工作者和家長合作,設計了適用於從學前教育到12年級的教育解決方案,涵蓋14種語言。MCE是唯一一家與劍橋國際教育合作的亞洲出版商。www.mceducation.com媒體垂詢:Shahidah HamsahName:shahidahhamsah@mceducation.com[1]https://www.unicef.org/kyrgyzstan/media/8021/file/Education%20Joint%20Sector%20Review.pdf來源:Marshall Cavendish Education Pte Ltd Copyright 2024 亞太商訊 via SeaPRwire.com.
More
日本厚生勞動省批准了莫德納公司針對SARS-COV-2 JN.1變異株的COVID-19 mRNA疫苗的部分變更申請 ACN Newswire

日本厚生勞動省批准了莫德納公司針對SARS-COV-2 JN.1變異株的COVID-19 mRNA疫苗的部分變更申請

馬薩諸塞州劍橋, 2024年8月24日 - (亞太商訊 via SeaPRwire.com) - Moderna, Inc.(納斯達克股票代碼:MRNA)今日宣佈,已獲得日本厚生勞動省(MHLW)批准其COVID-19 mRNA疫苗Spikevax更新配方的部分變更申請,該疫苗針對SARS-CoV-2 JN.1變異株。 “我們感謝日本厚生勞動省對我們更新後的COVID-19 mRNA疫苗作出的批准決定,”莫德納首席執行官Stéphane Bancel表示。“確保人們接種最新更新的COVID-19疫苗,以防範現有流行的毒株,這是至關重要的。隨著COVID-19疫苗接種變得像季節性流感疫苗一樣成為常規接種,個人將能夠在今年秋季同時接種更新後的COVID-19疫苗和流感疫苗。” 2024年5月,日本衛生部的一個專家小組建議,將COVID-19疫苗更新為針對JN.1奧密克戎子變異株家族的疫苗,用於2024/2025年度的國家免疫計劃(NIP)。這一指導意見與世界衛生組織(WHO)COVID-19疫苗成分技術諮詢小組(TAG-CO-VAC)關於採用單價JN.1譜系作為COVID-19疫苗抗原成分的建議保持一致。日本的國家免疫計劃(NIP)將為65歲及以上的人群,以及符合條件的60至64歲人群提供COVID-19疫苗接種服務。日本是全球老齡化比例最高的國家,大約30%的人口年齡在65歲及以上。鑑於呼吸道病毒是65歲以上人群的主要疾病負擔,國家免疫計劃對於減輕疾病負擔以及未來減輕醫療系統壓力至關重要。要求在常規計劃之外接種COVID-19疫苗的個人可以選擇自費自願接種。 今年7月,莫德納與三菱田邊製藥株式會社達成協議,共同推廣莫德納的mRNA呼吸道疫苗組合在日本的使用,其中包括Moderna的COVID-19疫苗Spikevax。 關於ModernaModerna是mRNA醫學領域的開創者。透過推動mRNA技術的發展,Moderna正在重新構想藥物的製造方式,改變我們對待和預防疾病的方式。透過在科學、技術和健康的交匯處工作超過十年,該公司以前所未有的速度和效率開發了藥物,包括最早和最有效的COVID-19疫苗之一。Moderna的mRNA平台使得能夠開發用於傳染性疾病、免疫腫瘤學、罕見疾病和自體免疫疾病的治療和疫苗。憑藉著獨特的文化和由Moderna的價值觀和思維方式推動的全球團隊,Moderna致力於透過mRNA藥物為人們提供最大的可能影響。有關Moderna的更多信息,請訪問modernatx.com,並在X(前身為Twitter)、Facebook、Instagram、YouTube和LinkedIn上與我們聯繫。前瞻性陳述本新聞稿包含根據1995年《私人證券訴訟改革法案》修訂版的定義所指的前瞻性聲明,包括以下聲明:日本厚生勞動省授權Moderna更新的針對JN.1的COVID-19疫苗;Moderna更新後的COVID-19疫苗誘導免疫反應並提供針對流行SARS-CoV-2變種保護的能力;以及Moderna為支持日本COVID-19國家免疫計劃而供應其COVID-19疫苗的能力。本新聞稿中的前瞻性聲明既不構成承諾也不構成保證,您不應過度依賴這些前瞻性聲明,因為這些聲明涉及已知和未知的風險、不確定性和其他因素,其中許多超出了莫德納的控制範圍,可能導致實際結果與這些前瞻性聲明所表達或暗示的內容存在重大差異。這些風險、不確定性和其他因素包括但不限於,Moderna在2023年12月31日結束的財政年度的年度報告中「風險因素」一節中描述的那些風險和不確定性,該報告已向美國證券交易委員會(SEC)提交,並在Moderna隨後向SEC提交的文件中描述,這些文件可在SEC的網站www.sec.gov上取得。除非法律規定,Moderna不承擔更新或修訂本新聞稿中包含的任何前瞻性陳述的意圖或責任,以反映新資訊、未來發展或其他情況。這些前瞻性陳述是基於Moderna當前的期望,並僅截至本新聞稿的日期。聯絡方式:媒體:International mediaLuke Mircea-WillatsSenior Director, International CommunicationsLuke.mirceawillats@modernatx.comModerna JapanCommunications & Mediajapan-pr@modernatx.com投資者:Lavina TalukdarSenior Vice President & Head of Investor Relations+1 617-209-5834Lavina.Talukdar@modernatx.com[1] 符合條件的個人包括:60至64歲且患有嚴重心臟、腎臟或呼吸功能障礙,嚴重限制日常活動的個人,或因人類免疫缺陷病毒(HIV)導致免疫缺陷,致使日常生活極其困難的個人。來源:Moderna, Inc. Copyright 2024 亞太商訊 via SeaPRwire.com.
More
駿碼半導體公佈中期業績 錄得收益約109.0百萬港元  LED封裝膠銷售量再增高 ACN Newswire

駿碼半導體公佈中期業績 錄得收益約109.0百萬港元 LED封裝膠銷售量再增高

香港, 2024年8月23日 - (亞太商訊 via SeaPRwire.com) — 駿碼半導體材料有限公司(「駿碼半導體」或「公司」,連同其附屬公司統稱「集團」,股份代號:8490.HK)欣然宣佈截至2024年6月30日止六個月(「該期間」)之未經審核業績。於該期間,集團錄得收益約109.0百萬港元(2023年上半年:約101.6百萬港元)。鍵合線產品錄得收益增加10.7%至約 58.3百萬港元(2023年上半年:約52.6百萬港元),而封裝膠產品的收益則輕微增加2.8%至約46.8百萬港元(2023年上半年:約45.6百萬港元)。收益增加乃由於本集團產品的銷量增加所致。在2023年全球經濟受壓的背景下,人工智能產業鏈呈現快速增長勢頭。踏入2024年,人工智能將進一步推動晶片運算能力、儲存容量和能源效率的提升,從而促進半導體架構和先進封裝的創新,有關進步有望帶來新的市場增量。根據國際半導體產業協會的「年中總半導體設備預測—OEM角度」報告,預測原設備製造商 (「OEM」)於2024年的全球半導體製造設備銷售額將創下新產業紀錄,達到1,090億美元,按年增加3.4%。由前端及後端市場發展帶動,半導體製造設備的銷售額預計將持續增長至2025年,預計銷售額將達到1,280億美元新高。聚焦半導體封裝行業,中國國內製造商正逐步從傳統封裝向先進封裝技術拓展市場佔有率。人工智能、高性能計算等新需求的帶動下,需求不斷增長,加速了中國半導體產業的戰略佈局,繼而促進了該拓展。尤其是在先進封裝所需的材料方面,由於其技術複雜度高、製程影響大、國產率相對較低,因此受到業界的高度關注。展望未來,鑒於人工智能的快速發展,本集團將繼續尋求新的業務合作,並專註於先進半導體材料的創新,以應用於電動汽車、微型LED顯示、人工智能及5G通信行業。此外,集團亦會投放更多資源於5G及半導體產業的上遊封裝材料,預期這將成為本集團的另一增長領域。展望未來,儘管國際形勢不明朗,董事會堅信集團在半導體封裝材料行業的既有地位、競爭優勢及靈活的業務策略,將可克服復雜環境影響,實現長期增長,為股東帶來最大回報。-完-關於駿碼半導體材料有限公司駿碼半導體材料有限公司(「駿碼半導體」)是國內半導體封裝材料行業龍頭企業之一,由周振基教授及周博軒博士於2006年共同創立,總部位於香港科學園區,研發及製造中心設在廣東汕頭,業務多點分佈大灣區及華東地區。駿碼半導體是一家專業從事研發、製造及銷售高精密鍵合線、灌封材料、粘結材料等半導體封裝專用物料的高新材料提供方。此新聞稿由慧悅公共關係顧問集團有限公司代表駿碼半導體材料有限公司發布如有垂詢,請聯絡慧悅公共關係顧問集團有限公司:Karena Ke電話:(852)9346-2934電郵:karena.ke@intelligentjoy.com Copyright 2024 亞太商訊 via SeaPRwire.com.
More

AI提效顯著,上市以來連續盈利,粉筆2024中期淨利潤增幅240.9%

香港, 2024年8月23日 - (亞太商訊 via SeaPRwire.com) — 8月23日,粉筆(02469.HK)發布2024年中期業績報告。截至2024年6月30日,粉筆實現營收16.3億元,與去年同期基本持平;淨利潤爲2.8億元,同比大漲240.9%,經調整淨利潤3.5億元,同比增長21.2%,上市以來粉筆連續三份財報淨利潤保持快速增長,盈利能力亮眼。粉筆創始人、CEO張小龍表示,粉筆將會繼續努力,在做好品質基礎上,平衡好産品質量和收入規模關係,始終把品質和效率放在第一位,同時持續加大對教研技術投入,尤其是AI技術的投入。“我們堅信對于教育培訓類産品,把品質做好一定會帶來市場占有率和收入規模增加,這種收入才是健康可持續有口碑的收入。只要堅持做正確的事,一定會迎來品質規模利潤的良性循環,以此回報各位用戶和投資人對我們的支持和信任。”1、毛利率、淨利率雙雙提升,發展穩健向好2024年,“穩就業”依舊是主旋律之一。據信達證券分析,國考+省考招錄人數穩定增長,報名人數彈性更强,2024年國考通過資格審查人數同增21.3%,實際參加考試人數同增47.7%,省考報名人數同增13.1%,在當前的就業環境下,公考熱情有望持續提升。考生參培需求預計持續釋放。從公告披露數據來看,作爲行業頭部企業,粉筆各項業務有序發展。截至2024年6月30日,粉筆平均月活躍用戶爲920萬。據粉筆介紹,OMO模式已經在其小班課程産品中全面普及,充分整合綫上綫下優質教育資源,爲用戶提供多元的産品選擇,和更具個性化的學習體驗。依托堅實的用戶基礎和優越的産品力,粉筆業務潜力有望得到進一步開發。2024年上半年,粉筆毛利爲8.8億元,同比增長3.2%,毛利率從去年同期的50.9%增加至54.2%;淨利潤率爲17%,去年同期爲4.8%,增幅顯著,體現公司産品市場競爭力增强,盈利水平保持强勁增長。2024年上半年,粉筆整體師均收入貢獻爲51.8萬元,經營效率不斷提升。此外,報告期內,粉筆圖書業務實現收入2.5億元,在總營收中占比與去年同期持平,爲用戶提供更全面的服務的同時,也保證了收入的多樣性。2、AI應用加速落地,鎖定優勢地位2024年,粉筆錨定科技創新,人工智能研發再上一個臺階,推出了首個職教領域垂域大模型,幷落地應用粉筆AI老師,不斷提升自身技術競爭力,爲下半年業績增長提前鎖定發展空間。報告期內,粉筆研發開支爲1.1億元。財報顯示,得益于人工智能技術及其他在綫技術賦能大幅提升授課效率,2024年上半年,粉筆收入成本爲7.5億元,與去年同期的8.3億元相比縮减了9.6%。尤其是培訓服務相關成本,縮减了11.6%至5.8億元。粉筆AI應用已經融入教研、教學、運營的各環節中,在面試點評、筆試輔導、客服等領域提供支持。在AI助力下,粉筆行業優勢地位凸顯。據介紹,2021年2月,一位精品班輔導老師同期可以服務40人左右,目前,一位老師同期最高可服務150人,效率提升可達275%。不光是效率,用戶體驗也隨之提升。在預測分功能輔助下,2022年省聯考行測到2024年省聯考行測,精品全程班用戶對應提分漲幅可以達到40%。據媒體報道,粉筆AI矩陣還在不斷擴展,包括申論AI老師、面試AI老師以及事業單位、教師項目的AI老師在內的産品正在開發中,有望成爲業績發展新的曲綫。在堅定技術投入的基礎上,粉筆始終對長期增長前景充滿信心。今年5月,粉筆公布了一項回購計劃,預計在2025年5月12日前不時在公開市場上購回價值總額不超過3億港元的公司普通股。據悉,截至2024年8月9日,粉筆已回購幷注銷普通股5423萬股,累計回購金額約2.3億港幣。粉筆表示,預計公司的收入可以穩健增長,在維持高質量教學品質的前提下,利潤率和運營效率仍有進一步優化的空間。粉筆發展前景也獲多家機構認可,天風證券、信達證券、方正證券、國泰君安等均給予粉筆“看好”“推薦”等評級。 Copyright 2024 亞太商訊 via SeaPRwire.com.
More

Weichai Power: Net profit attributable to shareholders of the parent increased by 50%

HONG KONG, Aug 23, 2024 - (ACN Newswire via SeaPRwire.com) - On 22 August 2024, Weichai Power (000338.SZ; 2338.HK) released its semi-annual report. According to the announcement, in the first half of 2024, Weichai Power achieved income of RMB 112.49 billion, a year-on-year increase of 6.0%; net profit attributable to shareholders of the parent was RMB 5.90 billion, a year-on-year increase of 51.4%; and net profit attributable to shareholders of the parent after deducting non-recurring profit and loss was RMB 5.48 billion, a year-on-year increase of 51.8%. At the same time, the Company announced its interim dividend payout plan for 2024, with a cash dividend ratio increased to 55%.Power System: Empowering and expanding product advantages with technology, steadily increasing market shareWeichai Power insisted on independent innovation, continuously accelerated the commercialization of scientific and technological achievements, and promoted the expansion of differentiated product advantages. It has launched the world's first diesel engine with body thermal efficiency of 53.09%, setting a new world record for four consecutive times; and launched a new generation of LNG engines, with overall improvements in power, reliability, economy, and comfort. In the first half of 2024, total engine sales volume of Weichai Power was approximately 400 thousand, representing a year-on-year increase of 9.8%. Among them, sales volume of heavy-duty truck engines reached approximately 161 thousand units, with a market share of 40.5%; market share of LNG heavy-duty truck engines reached 63.1%; and market share of 6x4 tractor-trailer engines with 500 horsepower and above reached 44.6%. Besides, the sales volume of M series engines of the Company reached approximately 3,600 units, and the product structure continued to improve, with overseas revenue accounting for 75.6%.Heavy-duty truck: Continued breakthroughs in segment markets, significant improvement in operational quality.Benefiting from the recovery of domestic demand and the gradual manifestation of China's heavy-duty truck export competitiveness, the heavy-duty truck industry has shown a trend of recovery. Shaanxi Heavy-duty Automobile continuously improves its product market competitiveness, with a focus on breaking through advantageous segment markets, achieving improvements in both production and sales scale and operational efficiency. In the first half of 2024, Shaanxi Heavy-duty Automobile sold approximately 63 thousand heavy-duty trucks, a year-on-year increase of 3.6%. Among them, sales volume of LNG heavy-duty trucks reached approximately 17 thousand units, an increase of 134.3% year-on-year; sales volume of new energy heavy-duty trucks reached 2,840 units, a year-on-year increase of more than doubling. At the same time, Shaanxi Heavy-duty Automobile has deeply explored the potential of overseas markets, with export volume of heavy-duty trucks reaching approximately 30 thousand units, a year-on-year increase of 15%, realizing the highest level in the same period in history.Agricultural equipment: Actively responding to the rural revitalization strategy, leading the industry's high-end transformation.Weichai Lovol Intelligent Agriculture focused on building three core capabilities of "smart agricultural machinery, precision agriculture, and digital agricultural services", actively promoted product transformation and upgrading, and leads China's agricultural machinery industry towards high end with its own high-quality development. In the first half of 2024, Weichai Lovol Intelligent Agriculture sold approximately 77 thousand units of various types of agricultural machinery, a year-on-year increase of 17.5%; the achievements of large-scale and high-end transformation were highlighted, with the proportion of tractors above 100 horsepower increasing by 8 percentage points year on year and the proportion of tractors above 200 horsepower increasing by 3 percentage points year on year. Weichai Lovol Intelligent Agriculture achieved revenue of approximately RMB 9.8 billion, a year-on-year increase of 28.1%, reaching the best level in the same period in history; achieved a net profit of approximately RMB 560 million, a year-on-year increase of 34.8%.Intelligent logistics: Revenue reaching a new historical high, significant increase in profitability.In the first half of 2024, Weichai Power's holding subsidiary, KION Group, achieved revenue of approximately EUR 5.74 billion, a year-on-year increase of 2%, reaching a new high in the same period in history. Among them, the forklift business achieved revenue of approximately EUR 4.31 billion, and the supply chain solutions business achieved revenue of approximately EUR 1.45 billion. Benefiting from improved operating quality and increased operational efficiency, KION Group's profitability continues to strengthen. In the first half of 2024, it achieved a net profit of approximately EUR 180 million, a year-on-year increase of 24.1%; the adjusted EBIT margin was approximately 7.8%, representing an increase of 1.6 percentage points year on year. Based on the strong development momentum in the first half of the year, KION Group has further confirmed its full-year performance outlook, defining its continued growth and positive operating expectations.In future, the Company will continue to seize the opportunities brought by the new quality productive forces and the transition from old to new drivers of growth, focus on value creation, reform deepening, layout optimization, and technological innovation, firmly promote in-depth reforms, strengthen development quality, reinforce development vitality and boost growth momentum. Changing gears and speed up to enhance growth force and gathering strength to promote development, the Company is accelerating to build a world-class company. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
InfoComm India 2024: The Largest Edition of the Pro AV Exhibition to Date ACN Newswire

InfoComm India 2024: The Largest Edition of the Pro AV Exhibition to Date

MUMBAI, INDIA, Aug 23, 2024 - (ACN Newswire via SeaPRwire.com) - InfoComm India, India’s foremost professional audiovisual (Pro AV) exhibition, is set to return to Mumbai from 3-5 September 2024 at the Jio World Convention Centre (JWCC). This year, InfoComm India 2024 expands beyond Pavilions 1 to 3 at JWCC, incorporating Jasmine Hall (at Level 3) for an even larger showcase of innovative solutions. It will showcase over 250 brands from more than 10 countries, including 35 first-time exhibitors. Registration is now open for professionals and businesses looking to deepen their Pro AV expertise.InfoComm India 2024, 3-5 September 2024, Jio World Convention Center, Mumbai | Attend over 48 free summit sessions, across 14 tracks, featuring insights from more than 50 industry leaders.Visitors can discover a plethora of solutions ranging from the latest in digital signage, to intelligent video conference systems, from artificial intelligence (AI) in LED virtual production to naked eye 3D displays, smart classroom solutions, interactive immersive projection mapping and more catering to a wide range of sectors such as education, finance, live events, urban development & smart cities. The exhibition will showcase top-tier products and innovations from renowned global brands and emerging industry players, including AERO, BENQ, Crestron, Harman, QSYS, Barco, AET, Samsung, and PeopleLink, along with WACOM, DVSI, Neotouch, Yotech Infocom, Onfinity Technologies and 30 more who are exhibiting for the first time at InfoComm India.With an expanded show floor space at Jasmine Hall, visitors can look forward to even more innovators in the Pro AV and technology space including TOYO, 4 Squares Corporation, Altex, Black Box and Wah Lee to name a few. AVIXA will also be making its presence felt at Jasmine Hall with interactive and knowledge-packed seminars hosted at its booth throughout the three days.InfoComm India 2024 expands beyond Pavilions 1 to 3 at JWCC, incorporating Jasmine Hall (at Level 3) for an even larger showcase of innovative solutions.The 2024 InfoComm India Summit will offer over 48 free-to-attend seminars across 14 specialized tracks led by over 50 industry leaders as speakers. A glimpse of the exciting lineup of sessions includes a kick-off overview “Navigating New Horizons: Insights and Innovations Shaping India’s Pro AV Landscape” led by David Labuskes, CTS, CAE, RCDD, Executive Director and CEO, AVIXA , ‘Live Events & Experiential Planning’ exploring Pro AV application for live events, as well as industry-focused sessions dedicated to smart cities, hospitality, and education sectors like "Future of Learning Spaces", “Securing the Future: Cybersecurity Strategies, Economics, and Risk Management”, Digital Signage in the AI-age which explores real-world strategies using AI, VR, and digital platforms for immersive experiences."India's digital transformation is truly inspiring," said June Ko, Executive Director of InfoComm India. "We see a vibrant energy and a thirst for innovation across the country. InfoComm India 2024 is our way of bringing together the brilliant minds and passionate hearts that are shaping this new era of technology in India. We envision InfoComm India as the premier destination for the Pro AV community to exchange ideas, foster partnerships, and collectively drive the industry forward.”Connection is at the heart of InfoComm India 2024. A host of networking opportunities are designed to connect attendees with industry experts, thought leaders, and peers. They include the Breakfast Networking Hour at Luminary Lounge (Jasmine Hall) on 2 and 3 September, 9.30am to 10.00am; Flashtrack seminars and networking events at AVIXA booth; daily New Technology and Products Show Floor Tours and more.InfoComm India 2024 will showcase over 250 brands, with 35 first-time exhibitors.For full details on exhibitors, products, summit agenda, registration, and sponsorship opportunities, visit www.infocomm-india.comTo access more press information of InfoComm India 2024, please visit: Digital Press Office KitFor more information, please contact:Rest of the WorldAngieEngMarketing DirectorInfoCommAsiaPteLtdangieeng@infocommasia.comIndiaSooraj DhawanDirectorFalcon Exhibitions Pvt. Ltd.sooraj@falconfirst.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More

濰柴動力:歸母淨利潤增超50% 分紅比例升至55%

香港, 2024年8月23日 - (亞太商訊 via SeaPRwire.com) — 2024年8月22日,濰柴動力(000338.SZ;2338.HK)發佈半年度報告。公告顯示,2024年上半年,濰柴動力實現營業收入1124.9億元,同比增長6.0%;歸母淨利潤59.0億元,同比增長51.4%;扣非後歸母淨利潤54.8億元,同比增長51.8%。同時,公司公佈2024年中期分紅派息方案,現金分紅比例提升至55%。動力系統: 科技賦能擴大產品優勢,市場份額穩步提升濰柴動力堅持自主創新,持續加快科技成果轉化,推動產品差異化優勢逐步擴大,發佈全球首款本體熱效率53.09%柴油機,連續四次刷新世界紀錄;發佈全新一代天然氣發動機,產品動力性、可靠性、經濟性、舒適性全面邁上新臺階。2024年上半年,濰柴動力各類發動機銷售約40萬台,同比增長9.8%。其中,重卡發動機銷售約16.1萬台,市場份額達40.5%;天然氣重卡發動機市場份額達63.1%;500馬力以上6x4牽引車發動機市場份額達44.6%;M系列發動機銷售約3600台,產品結構不斷優化,海外收入占比達75.6%。重卡整車:細分市場持續突破,運營品質顯著改善受益於內需恢復及中國重卡出口競爭力的逐步顯現,重卡行業呈現復蘇態勢。陝重汽持續提升產品市場競爭力,重點突破優勢細分市場,實現產銷規模和運營效益雙提升。2024年上半年,陝重汽重卡整車銷售約6.3萬輛,同比增長3.6%。其中,天然氣重卡銷售約1.7萬輛,同比增長134.3%;新能源重卡銷售2,840輛,同比實現翻番增長。同時,陝重汽深度挖掘海外市場潛力,重卡出口約3萬輛,同比增長15%,達歷年同期最高水準。農業裝備:積極回應鄉村振興戰略,引領行業高端化轉型濰柴雷沃智慧農業聚焦“智慧農機、精准農業、數位農服”三大核心能力建設,積極推動產品轉型升級,以企業自身高品質發展引領中國農機行業邁向高端。2024年上半年,濰柴雷沃智慧農業各類農機產品銷售約7.7萬台,同比增長17.5%;產品結構大型化、高端化轉型成果凸顯,100馬力以上拖拉機占比同比提高8個百分點,200馬力以上拖拉機占比同比提高3個百分點;實現營業收入約98億元,同比增長28.1%,創歷史同期最好水準;實現淨利潤約5.6億元,同比增長34.8%。智慧物流:收入再創歷史新高,盈利能力大幅提升2024年上半年,濰柴動力控股子公司德國凱傲集團實現收入約57.4億歐元,同比增長2%,創歷史同期新高。其中,叉車業務實現收入約43.1億歐元,供應鏈解決方案業務實現銷售收入約14.5億歐元。受益於經營品質改善及運營效率提升,凱傲集團盈利能力持續增強。2024年上半年實現淨利潤約1.8億歐元,同比增長24.1%;調整後息稅前利潤率約7.8%,同比提升1.6個百分點。基於上半年良好發展勢頭,凱傲集團進一步重申其全年業績目標,明確持續增長向好的經營預期。未來,公司將繼續搶抓新質生產力培育及新舊動能轉換帶來的發展機遇,聚焦價值創造、深化改革、優化佈局、科技創新,堅定推動縱深改革,厚實發展成色,增強發展活力,提升發展動能,換擋提速強引擎,凝心聚力促發展,加快創建世界一流企業。 Copyright 2024 亞太商訊 via SeaPRwire.com.
More
Web3 with Tobi & Brent to Host Exclusive Networking Event and AfterParty During Token2049 Singapore ACN Newswire

Web3 with Tobi & Brent to Host Exclusive Networking Event and AfterParty During Token2049 Singapore

Summary: Coinciding with F1 week and TOKEN2049 at the iconic Marina Bay Sands in Singapore, this edition of the global event series “Web3 with Tobi & Brent” will serve as a hub for the Web3 community, facilitating connections and idea exchanges among industry leaders and developers.The event will feature a headline set by renowned DJ Dillon Francis, with artists Jade Rasif, Nicole Chen, and CeVie joining the lineup to offer unparalleled entertainment alongside networking opportunities at the iconic MARQUEE Nightclub. Co-hosted by prominent Web3 entities such as 280 Capital, Biptap, Cytonic, BitcoinOS and TBV, and supported by key partners like Limewire, Altcoin Daily, ZkPass, Ripple, 10X Capital, yourPRstrategist (YPRS), XDC Plug and Play, FOMO Ventures, ShibaDino, KINO, LBank, and Bitrue, the event will attract significant industry figures and offer unique insights into the Web3 ecosystem.SINGAPORE, Aug 23, 2024 - (ACN Newswire via SeaPRwire.com) - "Web3 with Tobi & Brent," a premier event series in the Web3 community, is set to host a renowned networking event and afterparty on September 17, 2024, at MARQUEE, Marina Bay Sands, Singapore. Coinciding with the TOKEN2049 conference, the event is strategically delivering high-value networking with the signature “Web3 with Tobi & Brent” party experience. Entrepreneurs, investors, developers and industry KOLs are set to come together for a night to be remembered.The event begins at 9PM with a networking session, followed by an afterparty at the MARQUEE Nightclub from 10:00 PM until late. Following a lineup of incredible artists including CeVie, Jade Rasif and Nicole Chen, guests can look forward to a headlining performance by the internationally acclaimed DJ, Dillon Francis. Known not only for his electrifying beats but also for his comedic humor, Dillon has secured his place as a crowd favorite having performed at some of the world’s biggest music festivals, including Coachella, Tomorrowland, and EDC. The combination of top-tier attendees, entertainment, and service promise an exceptional experience that will make it an unforgettable night.The event is co-hosted by 280 Capital, a leading Web3 venture arm with $2 billion in assets under management; Biptap, the first decentralized, non-custody multichain crypto debit card and payment offramp solution; Cytonic, the world‘s first Multi-Virtual-Machine Blockchain, combining Bitcoin, Ethereum and Solana in a single chain; BitcoinOS, the Bitcoin Superchain with interoperable rollups with near trustless rails for BTC & Bitcoin-native assets; and TBV, an early-stage Web3 venture capital fund investing in top-tier projects globally. Supporting partners include ZkPass, LimeWire, 10X Capital, Bitrue, KINO, Ripple,, LBank, ShibaDino, FOMO Ventures, Altcoin Daily, XDC powered by Plug and Play, BoomFi, Hivello, Freename, Aquanow, FunFair Ventures, Petastic, Morningstar Ventures, KXVC and Founders Launchpad.“Web3 with Tobi & Brent” is also supported by prominent players in Web3 PR and media such as yourPRstrategist (YPRS), Cointelegraph, Cryptopolitan, CoinsCapture, Coinstelegram, Luna PR, MediaX Agency, and European Kid as well as community partners like Association Blockchain Asia, Cryptocurrency PH, Unity Labs, Arts DAO, and Crypto World Community and CryptoMondays Lisbon, which further amplify its reach. With its extensive network and high-profile partnerships, the event stands out as a key highlight of TOKEN2049, attracting industry insiders and enthusiasts alike.Due to the high demand and limited capacity guests are advised to arrive early, with doors opening at 9:00PM, to ensure entry.For more information and to register, visit: https://lu.ma/web3tobiandbrenttoken2049SG For the latest updates, join the Telegram group: https://t.me/+5KzXYg2cridmOGRlAbout Web3 with Tobi & BrentWeb3 with Tobi & Brent is a premier event series in the Web3 community, bringing together key industry figures for networking and collaboration. With a focus on fostering connections and sharing insights, these events serve as a hub for innovation and growth in the blockchain space.Company URL: https://linktr.ee/tobiandbrentContact: skye@tbv.xyzPR Contact: pr@yourPRstrategist.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More
2nd ASEAN Battery Technology Conference Announces New Collaborations and Expansion to Strengthen Southeast Asia Battery Ecosystem ACN Newswire

2nd ASEAN Battery Technology Conference Announces New Collaborations and Expansion to Strengthen Southeast Asia Battery Ecosystem

SINGAPORE, Aug 23, 2024 - (ACN Newswire via SeaPRwire.com) - The 2nd ASEAN Battery Technology Conference (ABTC) returned and strengthened the commitment to develop a close knitted battery development ecosystem among the Southeast Asian countries. Hosted in Singapore this year by the Singapore Battery Consortium at Singapore at the Shangri-La Rasa Sentosa between 21st and 23rd August 2024.The conference is also jointly organised by the alliance of leading battery associations in the region - the Thailand Energy Storage Technology Association, the National Battery Research Institute, the National Center for Sustainable Transportation Technology, NanoMalaysia, and the Electric Vehicle Association of the Philippines.Dr. Pimpa Limthongkul, Co-Chairman of ABTC and President of the Thailand Energy Storage Technology Association, said, "This year we are excited to see the expansion of what we have achieved since we last gathered together last year in Bali. Our alliance has grown from three to now six battery associations in Southeast Asia and we will continue to grow in strength. Witnessing the collaborations between the battery associations, private sector and academia is a celebration of how we are moving forward together to drive innovation for a more connected and eco-friendly future in the region.”On the second day of the conference, over 250 participants and the six leading battery associations in Southeast Asia witnessed the signing of three new Memorandums of Understanding or MoUs that will further the development of batteries in the region. From L to R: Prof. Nonglak Meethong (Professor, Khon Kaen University), Mr. Larry Poon (Business Development Manager, INV CORPORATION PTE. LTD.), Dr. Rezal Khairi Bin Ahmad (CEO, NanoMalaysia Berhad), Mr. Bryan Oh (CEO, NEU Battery Materials Pte Ltd) Mr. Freddie Kim (Managing Director, SAMSUNG SDI SOUTHEAST ASIA), Dr. Sing Yang Chiam, Technical Director Singapore Battery Consortium.Three Memorandums of UnderstandingGigafactory Malaysia (GMSB) and NEU Battery Materials (NEU) to Collaborate on Lithium Battery Recycling DevelopmentThe collaboration will focus on developing “Gigafactory” level operations and manufacturing of innovative battery technologies incorporating nanomaterials for mobility and stationary applications. This collaboration is the progression of the Memorandum of Understanding (“Memorandum”) signed in Bali, Indonesia at the 2023 ASEAN Battery and Electric Vehicle Technology Conference (ABEVTC) to promote cross-country collaboration within ASEAN on battery technology.Singapore-based, NEU, who are specialists in LFP battery recycling will ensure a steady supply of recycled battery material, like lithium carbonate and other metals are made available to GMSB’s Hydrogen-Electric-Vehicle-Battery (HEBATT) Centre for performance testing. GMSB is a subsidiary of NanoMalaysia.The testing of the recycled material is to ensure their viability and sustainability within the Malaysia battery ecosystem, which would expand to localised development of a lithium battery recycling ecosystem for the ASEAN region. NEU and GMSB will facilitate this supply and development based on spent battery material being used in an end-to-end ecosystem.This will also pave the way for the exploration of a joint-development programme for improved recycling efficiency between these two companies.Gigafactory Malaysia Sdn Bhd (GMSB) and Khon Khean University (KKU) to Collaborate on Manufacturing of Cells Developed by GMSBGMSB’s and KKU’s collaboration will leverage their joint expertise and resources, with KKU acting as the outsourced manufacturer for batteries developed by GMSB. The collaboration will also provide knowledge sharing in battery testing and certification that will lead to productivity advancements at GMSB's Hydrogen-Electric-Vehicle-Battery (HEBATT) Centre in Malaysia.This Memorandum of Understanding (MoU) is an extension of an agreement signed at the 2023 ASEAN Battery and Electric Vehicle Technology Conference (ABEVTC) in Bali, which involved key organisations from Singapore, Indonesia, Thailand, Malaysia, and the Philippines.Aligned with the ASEAN Battery Network's mission, this MoU aims to strengthen battery technology development within ASEAN.Institute of Materials Research and Engineering (IMRE), Singapore and INV Corporation to collaborate on Joint Research to Develop Hybrid Battery SeparatorsA Research Collaborative Agreement will be signed between the Institute of Materials Research and Engineering in Singapore and INV to develop the next generation hybrid battery separators, which will address the challenges of safety faced by current rechargeable batteries.This collaboration seeks to play on the strengths and IPs in solid state batteries developed in Singapore. INV is headquartered in Singapore and is the largest battery separator film manufacturer in the world. Its production plants are in Sweden and Malaysia.Samsung SDI Southeast Asia ExpansionSamsung SDI, Korean high performance battery manufacturer began production in Southeast Asia with its first facility in Malaysia in 1992 and built a second plant in Vietnam in 2010. It will also open a second plant in Malaysia in 2025.To better support its customers in the region, it recently opened two sales offices in Vietnam and Singapore, with Singapore as the region sales headquarters for South East Asia.It is also planning to open new sales offices in Malaysia, Indonesia, Thailand and Philippines.Samsung SDI’s core battery product in Southeast Asia is the “Prime Battery for Maximum Experience” or PRiMX for short. PRiMX batteries are high on performance, reliability and safety using high nickel (low cobalt) cathode and silicon anode.As the company's vision, expect to make the world greener and sustainable through innovative technology.Hosting of the ABTC is rotated among the co-organisers. In 2025, TESTA will host the ABTC in Thailand.For more information on the programme agenda, please visit our official site: https://reg.eventnook.com/event/ABTC2024/homeThe conference's anchor sponsor is Hyundai Motor Group Innovation Center Singapore (HMGICS), with the gala dinner sponsored by INV Corporation Pte Ltd.Gold sponsors include Amphenol Communications Solutions, Quantel Pte Ltd, Infineon Technologies Asia Pacific Pte Ltd, and Gotion Singapore Pte Ltd, while silver sponsors are Concord New Energy Group Limited, Kewell Technology Co.,Ltd., Metrohm Singapore Pte Ltd, TME Systems Pte Ltd.Additional sponsors include Samsung SDI Southeast Asia Pte. Ltd, Siemens Industry Software Pte Ltd, UL Standards & Engagement, and NEWARE Technology Limited. Publicity partners are the EV Association of Singapore, EV Association of Malaysia, and Turn Off Turn On Ventures.Media ContactPRecious Communicationsabtc@preciouscomms.comAbout ASEAN Battery Technology ConferenceASEAN Battery Technology Conference (ABTC) stands out as the premier battery conference in ASEAN, attracting an audience of over 250 participants. We look forward to engaging with a diverse range of participants, including cell manufacturers, pack integrators, and recycling companies. The mission of ABTC is to bring together regional battery expertise, creating unique opportunities within the global battery value chain.The primary objective of ABTC is to foster collaboration among stakeholders in the battery industry. We aim to facilitate insightful discussions covering various topics, such as advanced battery materials, prototyping, cell-to-pack technologies, and recycling strategies.In addition to these focal points, the conference will explore related aspects such as standards, interoperability, and the ongoing evolution of battery safety technology.Organisers of ABTCAbout Singapore Battery ConsortiumSingapore Battery Consortium (SBC) aims to foster strategic R&D partnerships amongst public research performers and industry players in developing and advancing battery technologies. SBC aims to develop and catalyze the local ecosystem in battery-related technologies through this platform. It is hosted at A*STAR and supported by the National Research Foundation Singapore (NRF). Over the past decade, commercial interest in battery development has been on the rise, keeping pace with demand for better battery performance and different performance characteristics for increasingly complex mobility and portable devices. To meet this demand, the Singapore Battery Consortium will bring research outcomes from our laboratories into the market by enabling researchers to understand business requirements, while giving companies access to the latest battery research and technologies to augment their product development efforts.About Thailand Energy Storage Technology Association (TESTA)TESTA or THAILAND ENERGY STORAGE TECHNOLOGY ASSOCIATION aims to help connect stakeholders, educate the public, promote understanding, and nurture technological advancements in energy storage technologies in Thailand. TESTA was officially registered on January 25, 2021, by 5 founding institutes including the National Science and Technology Development Agency (NSTDA), Khon Kaen University (KKU), King Mongkut’s University of Technology Thonburi (KMUTT), King Mongkut’s University of Technology North Bangkok (KMUT-NB), and Electric Vehicle Association of Thailand (EVAT). Over 60 members of the association include energy storage technology enthusiasts from various sectors ranging from academic, research institutes, public sectors, policymakers, and private industries.About National Center for Sustainable Transportation Technology (NCSTT)The National Center for Sustainable Transportation Technology (NCSTT), or Pusat Pengembangan Teknologi Transportasi Berkelanjutan, is from Indonesia and is a unique multidisciplinary research center focused on conducting, supporting and encouraging applied engineering and technology for transportation systems in Indonesia. NCSTT has been recognized globally as the research center which aims to foster the national transportation industry in developing national economics and welfare. NCSTT has built network linkages and research collaborations with national transportation stakeholders such as automotive, railway and aircraft industries, as well as research institutions and universities.About National Battery Research Institute (NBRI)The National Battery Research Institute (NBRI) was legally established on 17th December 2020 as The Center of Excellence Innovation of Battery and Renewable Energy Foundation, with Prof.Dr. Evvy Kartini as a Founder and Prof Alan J. Drew as Co-Founder. NBRI is Indonesia’s independent institute for electrochemical energy storage science and technology, supporting research, training, and education. NBRI aims to contribute to the overall research capacity and training environment in Indonesia in Battery Research. NBRI is a platform that brings together scientists, academicians, industry partners, the government and all stakeholders that focus on battery technology. The main goal of NBRI is to encourage and support a battery manufacturing industry using local resources, which will enable Indonesia to be independent in energy. The NBRI was supported by the UK Government’s Global Challenge Research Fund (GCRF), part of the Queen Mary University of London QR allocation.About Electric Vehicle Association of Philippines (eVAP)eVAP envisions a nation wherein the use of electric vehicles is highly promoted, encouraged and supported by its government and society to develop a transportation landscape that is one with the environment ecologically and economically. eVAP’s mission is to educate the public on environmental awareness, and the economic and ecological benefits of electric vehicles through the conduct of and/or participation in promotional activities.eVAP aims to accelerate society’s conversion from using gas-powered vehicles to electric vehicles and works with the government in the creation and implementation of legislation that will support and encourage the use of electric vehicles.About NanoMalaysiaNanoMalaysia Berhad was incorporated in 2011 as a company limited by guarantee (CLBG) under the Minister of Science, Technology and Innovation (MOSTI) to act as a business entity entrusted with nanotechnology commercialization activities. Some of its roles include commercialization of nanotechnology research and development, industrialization of nanotechnology, facilitation of investments in nanotechnology and human capital development in nanotechnology. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024 ACN Newswire

Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024

Seoul, Korea, Aug 23, 2024 - (ACN Newswire via SeaPRwire.com) - Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences advanced technologies industries, has secured three prestigious awards at the esteemed Korea Biopharma Excellence Awards (KBEA) 2024. The KBEA event, held in conjunction with the 13th Annual Biologics Manufacturing Korea & 6th Vaccine World East Asia 2024 on 13-14, August 2024, underscores Avantor’s exceptional achievements in downstream processing and single-use systems, as well as its leadership as a biopharma supplier in Korea.Left: Andrew Wong, Chief Executive Officer/General Manager of Shanghai Wotai Biotechnology, ChinaRight: James Hwang, Head - Biopharma Applications, AMEA, AvantorAvantor received the following awards:Best Bioprocessing Supplier Award: Downstream ProcessingBest Bioprocessing Supplier Award: Single Use SystemsOverall Biopharma Supplier of the YearThese accolades highlight Avantor's commitment to excellence and innovation in bioprocessing. The "Best Bioprocessing Supplier Award: Downstream Processing" acknowledges Avantor's products and solutions that enhance the efficiency and effectiveness of downstream processing in biopharmaceutical manufacturing. Supporting this success is Avantor's Korea Innovation Customer Support Center (ICSC), which serves as a hub of scientific collaboration and innovation. The ICSC team collaborates closely with customers, offering services that help improve yields, reduce production costs, and ensure efficient production.The "Best Bioprocessing Supplier Award: Single Use Systems" recognizes Avantor's pioneering single-use solutions for strengthening production capabilities, streamlining operations, and improve scalability for biopharmaceutical companies. Notably, this marks the fourth consecutive year that Avantor has received the "Best Bioprocessing Supplier Award: Single Use Systems," following wins in 2022, 2021, and 2020.The "Overall Biopharma Supplier of the Year" award is a testament to Avantor's comprehensive impact on the biopharma industry, reflecting the company's dedication to providing high-quality products and services that drive advancements in biopharmaceutical research and production.Jin Young Lee, Head, Biopharma, APAC, Avantor, expressed his gratitude for the recognition, stating, "We are incredibly honoured to receive these prestigious awards at the Korea Biopharma Excellence Awards 2024. These accolades underscore our relentless commitment to innovation and excellence in bioprocessing and reinforces our standing as a premier supplier in the biopharma industry. They are a testament to the hard work and dedication of our team in Korea, who strive to deliver solutions that enable our customers to deliver life-changing therapies to the patients who need them."James Hwang, Head of Biopharma Applications, AMEA, Avantor commented on the awards and said, “Receiving these awards is a testament to our relentless dedication to advancing bioprocessing capabilities. Our commitment to innovation is embodied in the work we do at the Korea Innovation Customer Support Center (ICSC). Our dedicated team of scientists and application experts at the ICSC help customers with process optimisation, troubleshooting, new product proof of concepts, and hands-on trainings to meet their evolving needs. These awards not only recognize our achievements but also highlight the importance of collaboration and customer-centricity in advancing the biopharma industry.”Avantor's recognition at the Korea Biopharma Excellence Awards 2024 follows its recent success at the Asia-Pacific Biopharma Excellence Awards 2024, where the company won five awards, further solidifying its leadership position in the biopharmaceutical industry.About AvantorAvantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visitavantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.Regional Media Contact::Swati ChhabraManager - Corporate Communications, AMEAAvantor91-9958-404-334swati.chhabra@avantorsciences.comGlobal Media Contact:Eric Van ZantenHead - External CommunicationsAvantor1-610-529-6219eric.vanzanten@avantorsciences.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Datacentre & Cloud Infrastructure Summit (DCCI) gears up to transform the Kingdom’s digital future ACN Newswire

Datacentre & Cloud Infrastructure Summit (DCCI) gears up to transform the Kingdom’s digital future

Riyadh, Saudi Arabia, Aug 22, 2024 - (ACN Newswire via SeaPRwire.com) - Having debuted in Saudi Arabia last year, Datacentre & Cloud Infrastructure Summit (DCCI) is pacing for a massive return to the country on 5 – 6 November 2024 at the luxurious JW Marriott Hotel in Riyadh. Poised to gather over 300 industry leaders, experts, and key decision-makers from across the country, the platform will delve into the latest trends, innovations, ground-breaking strategies and give a pulse of the Kingdom’s datacentre & cloud landscape.With global industries expanding their footprint in the Kingdom, cutting-edge events in Riyadh have become a regular phenomenon. In line with VISION 2030, DCCI aims to upgrade the Kingdom’s technology stance by bringing global expertise closer to its datacentre & cloud ecosystem that is pivotal for a diversified economy and paramount to its digital future.To share the latest updates concerning Saudi’s digital infrastructure especially from its datacentres & cloud landscape, DCCI is bringing none other than the top officials from the leading public & private organisations including but not limited to the Ministry of Saudi Arabia National Guard, Saudi Olympic & Paralympic Committee, Saudi Pro League, Saudi Basic Industries Corporation (SABIC), Saudi Entertainment Ventures and Saudi Payments.These officials are not just the leading voices from across sectors but also the embodiment of progress who will be seen taking insightful keynote sessions, engaging fireside chats and deep dive panel discussions on the most pressing topics.Some prominent topics from the summit include, ‘Revolutionizing Saudi Arabia's Digital Infrastructure Landscape’, ‘National Data Sovereignty and Upholding Data Privacy’, ‘A Cloud-Powered Future for a Digital Saudi Arabia’, ‘Reimagining Data Centre Cooling’, ‘Reengineering Data Architecture’, ‘Empowering Next-Generation data centres through AI-Powered Infrastructure’, ‘Sustainable and Green Data Centres for a Digital Saudi Arabia’ and others.Attendees will also get the opportunity to explore the latest datacentre and cloud solutions as the platform will feature a stellar lineup of solution providers including but not limited to Edarat, Legrand Data Center Solutions, Daikin Air Conditioning Saudi Arabia, C&D Technologies, Corning, Hasoub, Austin Hughes, Nlyte Software, Sunbird Software, SETRA, Belden, Rittal, and many more.During the course of two days, DCCI will present an unparalleled opportunity to learn the latest intel, shake hands and network with industry’s very best, have one-on-one interactions with hand-picked profiles and last but not least forge strategic partnerships for growth & development.Organiser and CEO of Tradepass, Sudhir Ranjan Jena stated his organisation’s exemplary vision behind bringing this platform to the Kingdom, “The Datacentre & Cloud Infrastructure Summit (DCCI) is an effort towards powering an era that comes entwined with progress and global collaborations. With a focus on Saudi Arabia’s booming digital infrastructure landscape, DCCI will be a cornerstone for driving the latest datacentre & cloud innovations in the country that’s intrinsic to the Kingdom’s post-oil economy.”About TradepassProviding access to the global emerging markets, Tradepass brings together people, products and solutions to power events for unparalleled business and networking opportunities. Being the most accredited event company, it helps organizations: enter new markets, grow sales pipeline, close prospects, raise capital and identify the right solution-providers.As a deal facilitator, Tradepass is always determined about exposing the most agile liquid growth markets, to enable all-round scalability and growth.For more information about the event, log on to:https://saudi.dccisummit.com/Media contact:Shrinkhal SharadPR & Communication Leadinfo@tradepassglobal.com+ (91) 80 6166 4401Tradepass Copyright 2024 ACN Newswire via SeaPRwire.com.
More

Everest Medicines Announces the Initiation of an Investigator-Initiated Clinical Trial (IIT)

SHANGHAI, Aug 22, 2024 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK, “Everest”, or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced the launch of an Investigator-Initiated Clinical Trial (IIT) for a personalized mRNA cancer vaccine, EVM16, under the study EVM16CX01, at the Peking University Cancer Hospital and Fudan University's Cancer Hospital. This trial is designed to assess the safety, tolerability, immunogenicity, and preliminary efficacy of EVM16 injection as a monotherapy and in combination with PD-1 antibody for patients with advanced or recurrent solid tumors. EVM16CX01 is the first-in-human (FIH) trial for EVM16.EVM16 is a novel personalized therapeutic mRNA cancer vaccine independently developed by Everest. EVM16 contains neoantigens with high immunogenicity potential that are predicted based on the unique tumor mutations of each patient by Everest’s proprietary neoantigen prediction algorithm. The vaccine uses a lipid nanoparticle (LNP) delivery system to efficiently deliver neoantigen-encoded mRNA in vivo, activating neoantigen-specific tumor-killing T cells and inhibiting tumor growth."EVM16 is the first personalized mRNA cancer vaccine independently developed by Everest using our proprietary mRNA platform. The initiation of this clinical trial is an important milestone that demonstrates our commitment to discover and develop a new generation of mRNA immunotherapies for cancer and autoimmune diseases.” said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines.“While establishing leadership positions in nephrology, infectious disease, and autoimmune diseases, Everest will also focus on innovative modalities such as therapeutic mRNA vaccines. We look forward to seeing personalized cancer vaccines become a new clinical treatment method to serve more patients."According to the Globocan’s data in 2022, there were 19.976 million new cancer cases globally, with 9.744 million cancer-related deaths1. In the last few decades, Immunotherapy including checkpoint inhibitors has become an important part of treating some cancer types. However, they are only effective for some patients, and there is an urgent need to develop new generations of immunotherapies, such as personalized mRNA cancer vaccines, that have demonstrated early promise in clinical development. In preclinical studies, vaccination with EVM16 stimulated a strong neoantigen-specific T cell response in different mouse models and showed significant tumor growth inhibition in the syngeneic B16F10 mouse melanoma model. Preclinical data also demonstrated that the combination of EVM16 and a PD-1 antibody has synergistic effect, which supports the clinical application of the combination of EVM16 with checkpoint inhibitors. In preclinical toxicity studies, repeated dosing with EVM16 was well tolerated and safe. Taken together, the preclinical immunogenicity, efficacy and safety studies demonstrate that EVM16 is safe and has potential to bring benefits to cancer patients.Everest has built end-to-end capabilities across its proprietary mRNA platform. Our R&D team is developing multiple mRNA-based therapeutic products, as well as next generation lipid nanoparticle (LNP) delivery systems to enhance cell-mediated immune response. Our mRNA manufacturing facility in Jiashan, Zhejiang Province in China is designed to comply with global cGMP standards and is able to produce at clinical- and commercial-scale. Everest owns full global intellectual property rights to its mRNA therapeutic programs.Reference:1.Globocan 2022: https://gco.iarc.who.int/media/globocan/factsheets/populations/900-world-fact-sheet.pdfAbout EVM16EVM16 is a novel personalized mRNA cancer vaccine independently developed by Everest Medicines Limited.. EVM16 contains neoantigens with high immunogenicity potential which are predicted by Everest-proprietary algorithm and uses an LNP delivery system to efficiently deliver mRNAs that express tumor neoantigens into the human body. After vaccination with EVM16, neoantigens-encoding mRNAs are delivered into cells to produce neoantigen peptides, which activate neoantigen-specific T cell immune responses to kill tumor cells, thereby inhibiting tumor growthAbout EVM16CX01 studyThe study is a FIH, dose escalation and expansion study to evaluate the safety, tolerability, immunogenicity, and initial efficacy of EVM16 injection as a single and in combination with PD-1 antibody in subjects with advanced or recurrent solid tumors.,. The primary objectives are to evaluate the safety and tolerability of EVM16 monotherapy and EVM16 in combination with PD-1 antibody in subjects with advanced or recurrent solid tumors, and to determine the recommended phase 2 dose (RP2D) of EVM16. The secondary objectives are to evaluate the immunogenicity of EVM16, and the initial efficacy of EVM16 in combination with PD-1 antibody in subjects with advanced or recurrent solid tumors.About Everest MedicinesEverest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record from both leading global pharmaceutical companies and local Chinese pharmaceutical companies in high-quality discovery, clinical development, regulatory affairs, CMC, business development and operations. Everest Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company’s core therapeutic areas of renal diseases, infectious diseases and autoimmune disorders.For more information, please visit its website at www.everestmedicines.com.Forward-Looking Statements:This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law. Copyright 2024 ACN Newswire via SeaPRwire.com.
More

雲頂新耀宣佈 自主研發的新型mRNA個性化腫瘤治療性疫苗正式啟動臨床試驗

上海, 2024年8月22日 - (亞太商訊 via SeaPRwire.com) — 雲頂新耀(HKEX 1952.HK)是一家專注於創新藥研發、臨床開發、製造和商業化的生物製藥公司,今日宣佈正式啟動一款個性化腫瘤疫苗EVM16的研究者發起的臨床試驗項目(IIT)EVM16CX01。該研究由北京大學腫瘤醫院和復旦大學附屬腫瘤醫院發起,用於評估EVM16注射液單藥及聯合PD-1抗體治療在晚期或復發實體瘤受試者的安全性、耐受性、免疫原性和初步療效的劑量遞增及擴展研究。這是EVM16開展的首次人體試驗。EVM16是一款雲頂新耀自主研發的新型mRNA個性化腫瘤治療性疫苗,根據每位患者特有的腫瘤細胞突變,使用自主研發的人工智能算法,預測出具有較高免疫原性潛力的新抗原。通過脂質納米顆粒(LNP)遞送系統在體內進行高效的抗原呈遞,激活新抗原特異性T細胞,進而達到殺傷腫瘤細胞和治療癌症的目的。雲頂新耀首席執行官羅永慶表示:「EVM16是雲頂新耀自主研發的首款個性化mRNA腫瘤疫苗,此次臨床試驗項目的正式啟動意味著公司基於自主知識產權的mRNA平台所開發的腫瘤疫苗產品進入人體試驗階段,有望為腫瘤治療領域開發出新一代免疫療法。在構建腎科、感染、自身免疫性疾病領導地位的同時,雲頂新耀也快速進入腫瘤治療性疫苗等創新性治療領域,開拓新藍海。我們期待早日看到個性化腫瘤疫苗成為新的臨床治療手段,服務更多患者。」Globocan 2022年統計數據顯示,全球新發腫瘤人數1997.6萬人,因腫瘤死亡的人數為974.4萬人1。以PD-1/PD-L1抑制劑為主的免疫療法已經成為某些腫瘤治療非常重要的一部分,但僅對部分患者有效,腫瘤治療領域急需在此基礎上開發新一代免疫療法。個性化mRNA腫瘤疫苗則成為極具潛力的新一代免疫療法。在臨床前研究中,EVM16在多種小鼠模型中都激發出了強烈的新抗原特異性T細胞免疫反應,在小鼠黑色素瘤B16F10模型中實現了顯著的腫瘤生長抑制效果。雲頂新耀自研的算法已找到多個已知和之前未報道的腫瘤抗原,並且在多個獨立驗證研究中的預測表現相當或優於行業領先算法,臨床前數據還證明了EVM16疫苗與PD-1抗體聯用後的協同抗腫瘤效果,支持個性化腫瘤疫苗與免疫檢查點抑制劑在臨床中的聯用。在臨床前安全性評估試驗中,EVM16疫苗也展現了良好的安全性。這些結果綜合說明,EVM16注射液安全性良好,和免疫檢查點抑制劑聯用有望給腫瘤患者帶來更多臨床獲益。雲頂新耀利用自主知識產權的mRNA平台開發預防及治療性的mRNA產品,且擁有這些產品的全部知識產權及全部全球權益,並同時具備治療性mRNA產品全產業鏈的開發和製造能力。自研團隊基於經過臨床驗證的mRNA技術平台,多路徑開發腫瘤及其他治療藥物。目前正在研發多個mRNA腫瘤治療藥物,包括個性化腫瘤疫苗(PCV)、腫瘤相關抗原(TAA)腫瘤疫苗、免疫調節腫瘤疫苗,自體生成CAR-T產品 ,並開發新一代脂質納米粒(LNP)遞送系統以增強細胞介導的免疫反應。此外,雲頂新耀擁有自有商業化規模生產基地,位於浙江嘉善、符合全球良好生產規範(GMP)標準認證的生產基地,於2022年12月正式投入運行並成功完成了臨床批次生產,為實現mRNA技術平台的本土化研發、生產以及商業化運營奠定堅實的基礎。參考文獻:1. Globocan 統計資料: https://gco.iarc.who.int/media/globocan/factsheets/populations/900-world-fact-sheet.pdf關於EVM16EVM16是一款雲頂新耀醫藥科技有限公司自主研發的新型mRNA個性化腫瘤疫苗。EVM16是用菌種庫製備得到的線性化質粒DNA為模版,經體外轉錄、純化、除菌過濾製備出mRNA原液,採用脂質納米顆粒(LNP)技術將mRNA原液包封在由特定脂質組分組成的納米級脂質顆粒中,加入其他輔料經無菌灌裝製成。EVM16根據每位患者獨有的腫瘤細胞突變,使用自主研發的人工智能算法,預測出具有較高免疫原性潛力的新抗原,採用脂質納米顆粒(LNP)遞送系統將能高效表達腫瘤新抗原的mRNA遞送至人體內。受試者接種EVM16注射液後,mRNA被遞送入細胞內生成新抗原肽段,誘導機體產生新抗原特異性的T細胞免疫反應,來殺傷清除表達新抗原的腫瘤細胞而達到抑制腫瘤生長和治療癌症的目的。關於EVM16CX01研究項目此研究是一項評估EVM16注射液單藥及聯合PD-1抗體治療對晚期或復發實體瘤受試者的安全性、耐受性、免疫原性和初步療效的劑量遞增及擴展研究,也是EVM16的首次人體試驗。主要研究目的包括評估EVM16單藥以及EVM16聯合PD-1抗體在晚期或復發性實體瘤受試者中的安全性和耐受性,確定EVM16的II期推薦劑量(RP2D);次要目的包括評估EVM16在晚期或復發性實體瘤受試者中的免疫原性,以及評估EVM16聯合PD-1抗體在晚期或復發性實體瘤受試者中的初步有效性。關於雲頂新耀雲頂新耀是一家專注於創新藥和疫苗研發、臨床開發、製造和商業化的生物製藥公司,致力於滿足亞洲市場尚未滿足的醫療需求。雲頂新耀的管理團隊在中國及全球領先製藥企業從事過高質量研發、臨床開發、藥政事務、化學製造與控制(CMC)、業務發展和商業化運營,擁有深厚的專長和豐富的經驗。雲頂新耀已打造多款疾病首創或者同類最佳的藥物組合,公司的治療領域包括腎科疾病、感染性和傳染性疾病、自身免疫性疾病。有關更多信息,請訪問公司網站: www.everestmedicines.com前瞻性聲明本新聞稿所發佈的信息中可能會包含某些前瞻性表述,乃基於本公司或管理層在做出表述時對公司業務運營情況及財務狀況的現有看法、相信、和現有預期,可能會使用“將”、“預期”、“預測”、“期望”、“打算”、“計劃”、“相信”、“預估”、“確信”及其他類似詞語進行表述。這些前瞻性表述並非對未來業績的保證,會受到風險、不確定性及其他因素的影響,有些乃超出本公司的控制範圍,難以預計。因此,受我們的業務、競爭環境、政治、經濟、法律和社會情況的未來變化及發展等各種因素及假設的影響,實際結果可能會與前瞻性表述所含資料有較大差別。本公司及各附屬公司、各位董事、管理人員、顧問及代理未曾且概不承擔更新該稿件所載前瞻性表述以反映在本新聞稿發佈日後最新信息、未來項目或情形的任何義務,除非法律要求。 Copyright 2024 亞太商訊 via SeaPRwire.com.
More
樂普生物公佈2024年中期業績 ADC管線取得重大進展  核心産品營收大增一倍 ACN Newswire

樂普生物公佈2024年中期業績 ADC管線取得重大進展 核心産品營收大增一倍

香港, 2024年8月22日 - (亞太商訊 via SeaPRwire.com) —聚焦於腫瘤治療領域的創新型生物製藥公司──樂普生物科技股份有限公司(「樂普生物」或「公司」,股份代號:2157.HK) 公佈2024年中期業績。作為一家立足中國、面向全球的聚焦於腫瘤治療領域(尤其是靶向治療及免疫治療)的創新型生物製藥企業。樂普生物致力於通過先進的ADC技術開發平台開發創新型ADC,並旨在開發出更優化、更創新的藥物,更好地填補癌症患者的臨床需求缺口。公司致力於通過內部研發與戰略合作相結合的方式持續開發市場差異化管線,加強自主生產能力。目前,樂普生物已戰略性佈局了多個腫瘤產品管線。就臨床階段候選藥物而言,公司的產品中有一種臨床 / 商業化階段候選藥物;七種臨床階段候選藥物(包括一種透過合營企業共同開發的藥物);及三種臨床階段的候選藥物的聯合療法。其中一種候選藥物已獲得兩種靶向適應症的上市批准,其他適應症臨床試驗正在進行中。商業化稳定再超億元 核心產品銷售較去年同期增加一倍於報告期內,公司在推進產品管線及業務營運方面均取得重大進展,其中核心產品普佑恆®(普特利單抗注射液)的銷售收入達人民幣94.8百萬元,較2023年同期增加一倍,為公司收益人民幣133.3百萬元之主要貢獻。ADC管線及其與癌症免疫的聯合療法亦取得多項重大進展。而於創新平台研發的候選藥物臨床前獲得良好數據。於2023年4月,普特利單抗已成功獲納入用於治療黑色素瘤和MSI-H/dMMR實體瘤的2023年CSCO及CSGO指南,表明臨床KOL的高度認可。公司積極發展與各種業務渠道合作夥伴的合作關係。截至2024年6月30日,已在26個省份的採購平台上完成了招標程序,并已通過各種銷售渠道覆蓋約78個城市,將進一步擴大銷售網絡。ADC管線及其與癌症免疫的聯合療法取得重大進展公司的ADC候選藥物包括MRG003、MRG002、MRG004A、MRG001、MRG006A及CMG901。ADC管線及其與癌症免疫的聯合療法在上半年取得了重大進展。- MRG003:目前已完成NPC IIb期註冊性臨床研究的患者入組,預期將於2024年下半年於中國申報NDA。於2024年7月,公司已就MRG003用於治療R/M NPC於美國獲FDA授予BTD。MRG003與普佑恆®(普特利單抗注射液)的聯合療法:公司正在進行MRG003與普特利單抗聯合治療實體瘤的I/II期試驗,並已完成I期試驗。公司已觀察到良好的初步數據,該等數據已在2024年ASCO年會上以口頭匯報形式呈現。公司目前正在進行II期試驗並已觀察到良好的數據,該等數據計劃於2024年ESMO亞洲年會上呈現。- MRG002:已於中國完成HER2高表達BC肝轉移II期關鍵臨床試驗的患者入組,並觀察到良好數據,預期將於2024年CSCO上呈現。同時,公司正在進行HER2陽性BC的III期臨床試驗。MRG002與普佑恆®(普特利單抗注射液)的聯合療法:公司正在進行MRG002與普特利單抗聯合治療HER2表達實體瘤患者的II期試驗,並已於UC患者中觀察到良好的初步數據,預期將在2024年ESMO大會上呈現。- MRG004A:公司目前正在美國及中國進行實體瘤I期臨床研究,並已在PC、TNBC及CC中觀察到良好數據。實體瘤的相關初步I期數據已在2024年ASCO年會上以口頭匯報形式呈現。於2024年3月,MRG004A已獲FDA授予FTD,用於治療經過過往批准的療法治療的復發性或難治性PC。公司正在擴展I期臨床試驗PC患者亞組,以進一步探索MRG004A用於PC的更多潛力。- MRG006A:公司已於2024年AACR年會上公佈良好的臨床前數據。於臨床前研究中,MRG006A在多種CDX模型及HCC PDX模型中展現出強大的劑量依賴性的對腫瘤的生長抑制作用。同時,MRG006A亦在探索性毒理學研究中表現出良好的耐受性。根據良好的臨床前表現,公司已於中國獲得IND批准,且目前正在進行I期臨床研究,而該研究已於2024年8月實現首例患者入組。臨床前:佈局創新平台和創新靶點公司持續致力於建立和開發新型技術平台。除臨床驗證的vc-MMAE平台外,亦已為ADC候選藥物開發多個創新的鏈接體- 有效載荷平台,包括Hi-TOPi平台及其他早期階段的平台。於報告期內,公司的創新ADC平台及T細胞銜接器平台TOPAbody取得了重大進展。依託該等創新平台,已開發出兩款ADC候選藥物,分別為具有全球首創新藥潛力的MRG006A及具有全球同類最優潛力的MRG007,以及新一代T細胞激動性抗體CTM012。公司已觀察到良好的臨床前研究數據,並已於中國獲得MRG006A的IND批准。同時,亦正在高效推進MRG007及CTM012進入臨床研究階段。MRG006A及TOPAbody平台的臨床前數據已於2024年4月在AACR年會上呈現。未來展望展望2024年下半年,公司將繼續加快兩款主要ADC產品MRG003及MRG002的開發,邁向下一個里程碑。公司預期將於2024年下半年於中國就MRG003申報NDA,並將努力加快審批進程。公司亦將探索MRG004A及MRG006A等其他創新候選藥物的更多潛在臨床價值。同時,不斷探索管線內的聯合療法的潛在療效,以為更多患者帶來臨床效益。就創新分子而言,致力加強建設創新平台,並全力推進創新分子CTM012及MRG007進入臨床研究階段。2024年,公司將致力於深化市場營銷及商業化,並積極擴大在中國的市場足跡及產品知名度。這包括促進普佑恆®(普特利單抗注射液)的市場准入,繼續加快各級市場滲透,以進一步擴大市場份額。同時,公司將尋求通過各種方式提升品牌形象及市場對公司產品的認識。在國際方面,公司將加大在全球市場的拓展力度。由於ADC平台已獲跨國公司認可,預期公司的其他ADC產品將有更大的業務發展機會。日後,公司將堅持不懈地擴大國際網絡,並通過多項策略探索新的業務開發合作機會,以促進我們的發展及成功。 Copyright 2024 亞太商訊 via SeaPRwire.com.
More